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mechanism of immune activation has broad significance as many other bacterial pathogens manipulate host
cell processes, including immune cell signaling.
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ABSTRACT 
COMPLEMENTARY IMMUNE ROLES FOR INFECTED AND UNINFECTED CELLS 
DURING LEGIONELLA PNEUMOPHILA INFECTION 
Alan M. Copenhaver 
Sunny Shin 
The innate immune system responds to virulent pathogens, yet many pathogens 
manipulate host-signaling pathways, which should limit immune activation. The 
intracellular bacterium Legionella pneumophila is the cause of the severe pneumonia 
Legionnaire’s disease. L. pneumophila encodes a type IV secretion system (T4SS) to 
translocate bacterial proteins into the cytosol of infected host cells. Several of these 
bacterial effectors (Lgt1, Lgt2, Lgt3, SidI, SidL, Pkn5, and Lpg1489) inactivate host cell 
elongation factors involved in protein translation. Despite the ability of L. pneumophila to 
block host protein translation, inflammatory cytokines are still made during infection both 
in vivo and in vitro. It is unclear how infected cells can mount a cytokine response when 
host protein synthesis is blocked. By creating a fluorescence resonance energy transfer-
based system to track the activity of the T4SS in infected host cells, this study 
investigates how innate immune cells produce cytokines during L. pneumophila 
infection. In vitro, cells targeted by the T4SS of L. pneumophila are poor producers of 
cytokines critical for control of infection, such as TNF, IL-6, IL-12, and do not express 
CD86 in response to infection. Instead, uninfected, bystander cells produce these 
cytokines. Infected host cells do produce IL-1α and IL-1β de novo and transcribe many 
proinflammatory genes. During pulmonary infection, alveolar macrophages and 
neutrophils are targeted by the T4SS for translocation and contain viable L. 
pneumophila. These cells provide a niche for bacterial replication during infection, but 
also secrete IL-1 in response to virulent bacteria. Uninfected alveolar macrophages, 
neutrophils, as well as inflammatory monocytes and dendritic cells produce TNF during 
L. pneumophila infection in vivo. Inflammatory monocytes and dendritic cells also 
increase CD86 expression during infection. Importantly, this bystander TNF production 
and CD86 expression requires IL-1 signaling, as mice deficient for the IL-1R have 
diminished levels of TNF and CD86 expression during infection. These data suggest that 
infected cells have mechanisms to overcome protein synthesis inhibition to produce IL-1 
and that uninfected bystander cells are important contributors to the immune response 
during infection with L. pneumophila. This mechanism of immune activation has broad 
significance as many other bacterial pathogens manipulate host cell processes, 
including immune cell signaling. 
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CHAPTER 1 
INTRODUCTION 
 
Mammals provide large and diverse niches for microbial species. To date, every 
mammalian surface, including the skin, gastrointestinal tract, airways, and oral cavities 
are known to contain a multitude of living microbes including bacteria, archaea, viruses, 
and fungi (Bäckhed et al., 2005; Beck et al., 2012; Delwart, 2013; Dewhirst et al., 2010; 
Fontana et al., 2012; Grice and Segre, 2011; Hoffmann et al., 2013; Somerville, 1969). 
The vast majority of known microorganisms do not infect their hosts and induce disease. 
These organisms are referred to as non-pathogenic organisms or commensals. Some of 
these non-pathogenic organisms benefit their hosts by aiding digestion and nutrient 
uptake or by preventing colonization and infection of the host with pathogenic organisms 
(Casadevall and Pirofski, 2003; Case et al., 2009; Kamada et al., 2013a; 2013b; Kau et 
al., 2011). Pathogenic organisms are known to cause infection and disease, and thus 
their presence is detrimental to host organisms (Casadevall and Pirofski, 2003; Kamada 
et al., 2013a; 2013b; Kau et al., 2011; Mouchtouri et al., 2010; Nguyen et al., 2006). To 
detect pathogenic organisms, hosts encode and express pattern recognition receptors 
(PRR) (Janeway and Medzhitov, 2002). These PRRs detect conserved pathogen-
associated molecular patterns (PAMP) expressed by pathogens (Vance et al., 2009). 
These PAMPs include lipopolysaccharide (LPS), flagellin, foreign peptidoglycans, and 
foreign genetic material. However, commensal organisms express many of these 
PAMPs (Vance et al., 2009). For instance, LPS is a component of the Gram-negative 
cell wall, and thus is ubiquitously expressed by all Gram-negative organisms, including 
non-pathogenic microbes (Rietschel et al., 1994). Similarly, flagellin is a component of 
the Gram-negative flagellum, which is used by these organisms for locomotion and is not 
2	  
specifically associated with pathogenic organisms (Bardy et al., 2003; Neville et al., 
2013). Thus, PRRs alone cannot distinguish between non-pathogenic and pathogenic 
organisms. 
 
One distinction between commensal bacteria and their virulent counterparts is that many 
pathogens access the cytosol of host cells either by using specialized secretion systems 
to translocate bacterial products across host cell membranes or by using pore-forming 
proteins to disrupt host cell membranes and gain direct access to the cytosol (Krachler 
et al., 2011; Roy and Mocarski, 2007; Vance et al., 2009). Pathogens, such as Yersinia 
and Salmonella spp., encode type III secretion systems (T3SS) that form syringe-like 
structures to translocate bacterial effectors proteins across the plasma or phagosomal 
membranes (Cornelis, 2006; Viboud and Bliska, 2005). Burkholderia spp. also encode a 
T3SS, but unlike Yersinia and Salmonella spp, these bacteria utilize their T3SS to break 
out of the phagosome allowing for bacterial replication within the cytosol of host cells 
(Cornelis, 2006; Galyov et al., 2010). Other bacterial pathogens, such as certain Vibrio 
spp. and Listeria monocytogenes, utilize pore-forming proteins to either translocate 
effectors into the cell or disrupt phagosomal and other membranes allowing for access to 
the cytosol (De Haan and Hirst, 2004; Hamon et al., 2012). These secretion systems 
and pore-forming proteins often translocate bacterial effector proteins into the cytosol of 
host cells to manipulate host cell processes such as cytoskeletal rearrangement, 
vesicular trafficking, host cell signaling, and protein translation (Kahn et al., 2002; Roy 
and Mocarski, 2007). These mechanisms benefit the replication, and spread of the 
pathogens within hosts and are essential for their survival. 
 
 
 
3	  
A. Pathogenic manipulation of host cells 
A variety of bacterial pathogens encode effectors that modulate the activity of host cell 
kinases, ultimately altering host cell activation (Figure 1-1) (Krachler et al., 2011). Vibrio 
parahaemolyticus translocates the acetyltransferase VopA/P into host cells, which 
inactivates a number of MAP kinase kinases (MKK), ultimately inhibiting host cell growth 
(Selyunin et al., 2011; Trosky et al., 2007). Shigella flexneri encodes two effectors, OspF 
and OspG that inhibit extracellular signal-regulated kinases (ERK) and nuclear factor 
kappa-light-chain-enhancer of B cells NF-κB activation respectively, preventing the 
production of proinflammatory immune responses against the pathogen (Arbibe et al., 
2007; Kim et al., 2005; Kramer et al., 2007; Li et al., 2007). Yersinia spp. encode three 
effectors that alter host cell kinase activity. YopJ and its more pathogenic homolog YopP 
are acetyltransferases that inactivate both MAPK and NF-κB signaling in host cells via 
an unknown mechanism (Mukherjee et al., 2006; Palmer et al., 1998; Schesser et al., 
1998). Yersinia spp. encodes YopH that inhibits the protein kinases Fyn and focal 
adhesion kinase (FAK) signaling, preventing phagocytosis of the bacteria (Black and 
Bliska, 1997; Yuan et al., 2005). Finally, Yersinia spp. encode invasin that inhibits FAK 
signaling and prevents phagocytosis (Uliczka et al., 2009). 
 
Beyond inhibiting host cell signaling, a handful of pathogenic bacterial species encode 
toxins or effectors that inhibit protein translation by host cells (Fontana and Vance, 
2011). This host protein translation inhibition is thought to limit the production of many 
proteins involved in immune responses, including cytokines, antimicrobial agents, and 
lysosomal enzymes. This inability to produce proteins that are important for immune 
responses promotes infection (Fontana and Vance, 2011). Shigella spp. encode shiga 
toxin, a protein translation inhibitor that acts by cleaving the 28S RNA of the host 
ribosome (Sandvig and van Deurs, 1996). Corynebacterium diphtheriae express 
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diphtheria toxin that ribosylates elongation factor 2 in host cells, thus inhibiting protein 
translation (Wilson and Collier, 1992). Pseudomonas aeruginosa exotoxin ribosylates 
elongation factor 2 and therefore inhibits protein synthesis in a similar fashion (Wilson 
and Collier, 1992). Legionella pneumophila encodes seven known effectors that inhibit 
host protein synthesis via inhibition of host elongation factors or via currently unknown 
mechanisms (Barry et al., 2013; Belyi et al., 2006; 2008; Fontana et al., 2011; Shen et 
al., 2009). 
 
B. Immune responses during pathogenic manipulation 
Although bacterial pathogens manipulate host cells processes and therefore limit the 
immune response against these pathogens, successful immune responses are still 
mounted against many bacterial pathogens. Importantly, these immune responses are 
required for protection against infection. Several immune pathways are important for 
controlling Yersinia spp. infections, including the inflammasome, cytokine production, 
and T cell responses (Bohn and Autenrieth, 1996; Brodsky et al., 2010). Shigella spp. 
activate IFNγ production via IL-12 and IL-18 signaling that are critical for the survival of 
infected mice (Pore et al., 2012; Sansonetti et al., 2000; Way et al., 1998). P. aeruginosa 
infection induces inflammasome activation and neutrophil recruitment, both of which limit 
bacterial replication and dissemination (Hirche et al., 2008; Sutterwala et al., 2007). Like 
P. aeruginosa infection, Legionella pneumophila infection is controlled by a number of 
cytokines, the activation of the inflammasome, and neutrophil recruitment (Brieland et 
al., 1998; Ren et al., 2006; Tateda et al., 2001b). 
 
Thus, many pathogens express toxins, secretion systems, or effector proteins to block 
and manipulate host cell process, including the immune response, responses are still 
mounted against these pathogens and are critical for pathogen control and clearance. 
5	  
Little work, however, has uncovered how a successful immune response is mounted 
during pathogenic manipulation of host cells. Some pathways have been elucidated. 
Manipulation of MAPK and NF-κB signaling during Y. pseudotuberculosis infection 
results in a pro-inflammatory form of cell death known as necroptosis that has been 
shown to activate the immune response in infected mice (Philip et al., 2014). Likewise, 
signaling by pattern recognition receptors on host cells during protein translation 
inhibition induce or increase induction of a number of proinflammatory genes (Dunbar et 
al., 2012; Fontana and Vance, 2011; Fontana et al., 2012; McEwan et al., 2012). Yet, 
these phenomena have not been shown to be important in all bacterial infections and 
other pathways may exist to combat pathogenic manipulation. To study this 
phenomenon, we have utilized the pathogenic bacterium L. pneumophila. 
 
C. Legionella pneumophila ecology and infection 
Legionella pneumophila is a species of Gram-negative bacteria of the genus Legionella, 
which is found ubiquitously in freshwater environments including ponds, lakes, and 
streams (Fields, 1996). It parasitizes and replicates within various species of freshwater 
amoeba, including Hartmannella vermiformis and Acanthamoeba castellani. L. 
pneumophila can form planktonic biofilms on surfaces in freshwater environments (Piao 
et al., 2006). In its natural environment, L. pneumophila is generally harmless to 
mammalian hosts and no documented disease was caused by L. pneumophila until the 
20th century. Modern technology has allowed for the collection and aerosolization of 
vast quantities of fresh water for use in devices such as air conditioners, cooling towers, 
and misters. If the source of water used for aerosolization is contaminated with L. 
pneumophila, the bacteria become aerosolized where mammalian hosts can inhale 
them. This can lead to a severe form of pneumonia, known as Legionnaires’ disease, or 
cause a milder, flu-like illness known as Pontiac fever (Chandler et al., 1977; Fraser et 
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al., 1977; McDade et al., 1977; Winn et al., 1978). L. pneumophila was first discovered in 
Philadelphia in 1976 when 200 people attending the convention of the American Legion 
fell ill with a mysterious pneumonia that killed 34 individuals (Fraser et al., 1977; 
McDade et al., 1977). The source of infection was determined to be a contaminated air 
conditioner at the Bellevue hotel where many of the convention-goers were housed. 
Since then, many efforts have been made to prevent contamination of aerosolizing 
machines, although L. pneumophila infection still occurs. Cooling towers have been 
implicated as having the greatest ability to spread infection, as contaminated aerosols 
can travel up to 6 kilometers and infect individuals over a wide radius (Mouchtouri et al., 
2010; Nguyen et al., 2006; Vance et al., 2009). L. pneumophila is one of the leading 
causes of community-acquired pneumonia (Musher and Thorner, 2014; Rietschel et al., 
1994). There is no immunization for L. pneumophila; however, treatment with antibiotics 
resolves most infections (Bardy et al., 2003; Garau et al., 2010; Neville et al., 2013; Yu 
et al., 2004). 
 
Once in the lung of an individual, L. pneumophila encounters specialized macrophages 
of the airway space, known as alveolar macrophages (Chandler et al., 1977; Krachler et 
al., 2011; Roy and Mocarski, 2007; Vance et al., 2009). Infection of a single cell by L. 
pneumophila lasts approximately 16-24 hours, allowing for approximately five rounds of 
intracellular replication (Abu Kwaik et al., 1993; Cornelis, 2006; Horwitz, 1983; Horwitz 
and Silverstein, 1980; Viboud and Bliska, 2005). After this time, L. pneumophila is 
released from host cells via an unknown mechanism, resulting in death of the host cell. 
The bacteria are then able to disseminate to new cells. It is thought that some individuals 
have been exposed to L. pneumophila multiple times, as evidenced by anti-L. 
pneumophila serum titers of antibodies in the human population (Borella et al., 2008; 
Boshuizen et al., 2006; Cornelis, 2006; Galyov et al., 2010; Nagelkerke et al., 2003). 
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This indicates that most people control infection without subsequent disease. In those 
that cannot control infection, however, L. pneumophila disseminates throughout the body 
and bacteria can be found in the kidneys and heart (De Haan and Hirst, 2004; Hamon et 
al., 2012; Lowry and Tompkins, 1993). Patients who succumb to L. pneumophila 
infection often die of multi-organ failure (Fraser et al., 1977; Kahn et al., 2002; Roy and 
Mocarski, 2007). Smokers, individuals with chronic lung disease, recent transplant 
recipients, and immunocompromised individuals are at the greatest risk of acquiring L. 
pneumophila (Boer et al., 2006; Kool et al., 1998; Singh et al., 1993; Yu et al., 2004). 
The risk of L. pneumophila infection increases with age, but infection can occur in both 
children and young adults (Centers for Disease Control and Prevention (CDC), 2011). In 
2009, there were 3,522 reported cases of legionellosis in the US. Etiological studies 
estimate that only a third of all infections with Legionella spp. are reported and estimate 
that there are approximately 8,000 to 18,000 cases of legionellosis per year (Centers for 
Disease Control and Prevention (CDC), 2011). The prevalence of legionellosis has 
increased over the past decade, highlighting a need for better preventative measures, 
including proper water treatment (Parr et al., 2014). 
 
D. Legionella pneumophila type IV secretion system 
Legionella pneumophila expresses a specialized type IVb secretion system (T4SS) that 
is encoded by dot/icm genes and is essential for virulence as well as survival of L. 
pneumophila inside of host cells (Berger and Isberg, 1993; Hubber and Roy, 2010; 
Marra et al., 1992). This secretion system is similar, but genetically distinct from the type 
IVa secretion system expressed by P. aeruginosa and other Gram-negative bacteria 
(Vincent et al., 2006). Many of the components of this T4SS share genetic sequence 
and protein structure homology with the type IVa/VirB secretion system of such bacteria 
as Brucella spp. and Agrobacterium tumefaciens (Juhas et al., 2008). Despite this 
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homology, many aspects of the secretion system are unique and distinct from the type 
IVa secretion system (Nagai and Kubori, 2011). L. pneumophila lacking key components 
of the T4SS is still phagocytosed by amoebae and macrophages, but once inside host 
cells are unable to establish a replicative niche and are quickly shuttled to a degradative 
lysosome (Berger and Isberg, 1993; Marra et al., 1992).  About 30 genes encode the 
T4SS of L. pneumophila (Vincent et al., 2006). Deletion of some of these genes, such as 
dotA, dotB, icmC, and icmD render the T4SS completely inactive, whereas mutations in 
other genes such as icmS, dotF, icmF, and dotU allow for some T4SS activity to still 
occur, but for intracellular growth to be partially impaired (Nagai and Kubori, 2011; Vogel 
et al., 1996). Beyond replication and translocation, the dot/icm protein, IcmT, has a 
demonstrated role in allowing for L. pneumophila egress from host cells at the end of 
infection, but the exact mechanism for this escape is unknown (Molmeret et al., 2002). 
Research has resolved some of the base structure of the T4SS, mainly those 
components that are embedded in bacterial membranes or are localized to the bacterial 
cytosol (Sutherland et al., 2013). Unlike the type III secretion system and the type IVa 
secretion system, no syringe-like structure has been visualized for the T4SS of L. 
pneumophila and no pore-formation into host-derived membranes has been directly 
assessed (Nagai and Kubori, 2011). Therefore, the exact mechanism of T4SS-mediated 
translocation into the cytosol of host cells has not been described. 
 
For pathogenesis, L. pneumophila uses its T4SS to translocate bacterial effector 
proteins from the cytosol of the bacterium, through the phagosomal membrane into the 
cytosol of the host cell (Ensminger and Isberg, 2009; Ninio and Roy, 2007). To date, 
over 300 different effector proteins have been identified via screening, but the vast 
majority of these effectors have not been characterized (Burstein et al., 2009). The 
overall activity of the T4SS on host cells, however, has been described (Roy and 
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Mocarski, 2007). Translocation by the T4SS occurs in as little as five minutes post 
phagocytosis and translocation of effectors is thought to occur throughout the infectious 
cycle (Nagai et al., 2005; Ninio and Roy, 2007). Not all effectors are translocated at all 
times, however, and many effector proteins have opposing activities, suggesting that 
translocation is temporally orchestrated (Bardill et al., 2005; Kubori et al., 2010). Unlike 
with other secretion system, the cues for this temporal structure as well as the overall 
signal to induce translocation by the T4SS of L. pneumophila are not known (Qiu and 
Luo, 2013). Likewise, no definitive motif that targets bacterial proteins to the T4SS to be 
translocated has been identified, although many effectors have “disorganized” C-termini 
(Nagai et al., 2005). Other effectors, however, do not contain this disordered C-terminus 
and attachment of the disordered C-terminus alone to reporter constructs does not 
confer translocation (Nagai et al., 2005). Many of the T4SS effectors contain eukaryotic 
protein domains, such as ankyrin repeats and serine/threonine kinase domains (Ge et 
al., 2009; Pan et al., 2008). Likewise, the genes encoding these effectors have a lower 
GC content than other L. pneumophila genes on the bacterial chromosome, indicating 
that many effectors have been acquired via horizontal gene transfer, although this has 
not been directly demonstrated (Juhas et al., 2008). 
 
E. Type IV secretion system effectors 
The T4SS and many of the effectors are involved in preventing phagosomal maturation, 
as evidenced by a lack of maturation markers on the Legionella containing vacuole 
(LCV) (Roy et al., 1998). The T4SS promotes the assembly of the LCV, which is 
comprised of ER-derived vesicles and resembles an ER-like compartment by electron 
and fluorescent microscopy (Nash et al., 1984; Tilney et al., 2001). Much of vesicular 
transport in eukaryotic cells is controlled by the activity of small, Ras-like GTPases such 
as Arf1 (Goody and Itzen, 2013). Interestingly, many of the characterized T4SS effectors 
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alter the activity of GTPases, often by mimicking the activity of guanine nucleotide 
exchange factors (GEF) or GTPase activating proteins (GAP) and therefore can recruit 
or exclude various Rabs to the LCV (Goody and Itzen, 2013). RalF, one of best-
characterized effectors, recruits the host GTPase, Arf1, to the LCV, although deletion of 
RalF does not alter infection in mammalian macrophages (Amor, 2004; Nagai et al., 
2005). The effectors DrrA, SidD, LepB, LidA, AnkX, Lem3, and VipD have been 
demonstrated to interact with various host Rabs that are crucial regulators of ER-Golgi 
trafficking (Goody and Itzen, 2013). Similar to RalF, deletion of a single effector does not 
greatly alter infection in host macrophages, although minor effects on the LCV are 
evidenced. In fact, deletion of over 70 of the known effectors in combination does not 
alter L. pneumophila growth in murine macrophages, suggesting a large amount of 
redundancy in the activity of various effectors (O'Connor et al., 2011). Indeed, many 
effectors have overlapping activities or similar outcomes to pathogenesis. This 
redundancy appears to be required for a large host range, as deletion of various groups 
of effectors alters L. pneumophila replication in certain species of amoeba, but not in 
others (Ensminger et al., 2012; O'Connor et al., 2011). Currently, only one T4SS effector 
has a demonstrated, non-redundant role: SdhA (Creasey and Isberg, 2012). This 
effector is involved in preventing PlaA-induced lysis of the LCV during infection, and 
deletion of this effector releases L. pneumophila into the cytosol where it is degraded by 
autophagosomes, thus limiting growth of SdhA-deficient L. pneumophila in vitro 
(Creasey and Isberg, 2012). 
 
Although many of the effectors described have roles in preventing degradation of L. 
pneumophila and the creation and maintenance of the LCV, other T4SS effectors have 
different activities. The effector RomA is a methyltransferase that enters the nucleus of 
host cells and directly trimethylates histone H3 at the K14 residue, thereby globally 
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altering the chromatin landscape of infected host cells (Rolando et al., 2013). Autophagy 
of L. pneumophila can be blocked by the activity of the effector RavZ, which inactivates 
the host protein Atg8 (Choy et al., 2012). The effector LegK1 directly phosphorylates 
IκBα on the serine 32 and 36 residues, ultimately leading the activation of NF-κB (Ge et 
al., 2009). Like the effectors that alter ER-Golgi trafficking, however, deletion of these 
effectors either singly or in combination does not alter bacterial replication in murine 
macrophages. 
 
Many groups have observed a greater than 90% reduction in host protein synthesis 
during L. pneumophila infection that depends on the presence of a functional T4SS 
(Barry et al., 2013; Belyi et al., 2006; McCusker et al., 1991). Currently, seven effectors 
have been described to inhibit host protein translation (Figure 1-2). The effectors Lgt1, 
Lgt2, and Lgt3 are all glycosyltransferases that modify the host factor eEF1A, allowing 
for translational initiation but blocking elongation (Belyi et al., 2006; 2008). SidI binds 
and inactivates eEF1A, but can also bind the host factor eEF1Bγ (Shen et al., 2009). 
SidL, Pkn5, and Lpg1489 block host protein translation via unknown mechanisms (Barry 
et al., 2013; Belyi et al., 2013). Of note, these effectors are toxic to mammalian cells as 
demonstrated in ectopic expression assays (Fontana et al., 2011). Deletion of five or all 
seven of the known effectors, however, does not restore translational activity in infected 
cells and does not alter bacterial replication in vitro (Barry et al., 2013; Fontana et al., 
2011). These data suggest that other effectors may block host protein translation. 
Alternatively, macrophages treated with rapamycin and infected with avirulent L. 
pneumophila translate less protein than control-infected cells, and cells infected with 
virulent L. pneumophila exhibit suppressed mTOR signaling, suggesting that host mTOR 
signaling may also diminish translational activity in infected cells (Ivanov and Roy, 2013). 
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F. The immune response to Legionella pneumophila 
Despite the ability of the T4SS of L. pneumophila to alter many of the aspects of host 
cell physiology, including chromatin accessibility, ER-Golgi trafficking, authophagy, and 
protein translation, mammalian host cells still mount an immune response to virulent L. 
pneumophila (Friedman et al., 2002; Spörri et al., 2008). This immune response includes 
the production of many proinflammatory cytokines, the recruitment of innate and 
adaptive immune cells to the site of infection, and even the induction of a form of 
proinflammatory cell death (Casson and Shin, 2013; Neild and Roy, 2004; Tateda et al., 
2001a). The immune response to L. pneumophila is critical both in vitro and in vivo in the 
control and eventual clearance of bacteria from the host, as deletion or manipulation of 
many key immune pathways leads to subsequent increases in bacterial burden, 
increased bacterial growth in host phagocytes, and, in severe cases, the death of 
infected animals (Archer and Roy, 2006; Brieland et al., 1998; 1995; Derré and Isberg, 
2004; Hawn et al., 2006; Spörri et al., 2006). 
 
Many of the downstream signaling pathways activated by L. pneumophila in host cells 
have been characterized during in vitro and in vivo infection. The production of the 
majority of cytokines in vitro depends heavily on the activity of the adaptor protein 
myeloid differentiation primary response 88 (MyD88), and macrophages deficient for 
MyD88 have markedly reduced or absent production of many proinflammatory cytokines 
(Archer and Roy, 2006; Shin et al., 2008). MyD88-deficient mice are the most 
susceptible to L. pneumophila infection in vivo and die around 14 days post infection 
(Archer et al., 2010). The adaptor protein TIR-domain-containing adaptor-inducing 
interferon-beta (TRIF) plays a minor role in vitro in the induction of type I interferon and 
other cytokines, though the role of TRIF in vivo has never been investigated (Shin et al., 
2008; Stetson and Medzhitov, 2006). The kinase receptor-interacting serine/threonine-
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protein kinase 2 (Rip2) contributes mildly to IL-6 production in vitro and helps clear 
bacterial CFUs as well as induce production of IL-6, KC, and G-CSF in vivo (Archer et 
al., 2010; Frutuoso et al., 2010; Shin et al., 2008). IRF3 is induced by L. pneumophila 
infection and leads to the production of type I interferon (Lippmann et al., 2011; Stetson 
and Medzhitov, 2006). In vivo, this signaling pathway has little to no effect on bacterial 
burden. 
 
Many of the aforementioned signaling pathways converge upon classical immune 
signaling pathways. MyD88, TRIF, and Rip2 all lead to the induction of NF-κB signaling 
as measured by IκB degradation (Losick and Isberg, 2006; Shin et al., 2008). 
Interestingly, in the absence of these signaling adaptors, IκB degradation still occurs 
during WT L. pneumophila infection, but not T4SS-deficient bacteria, suggesting that 
additional signaling pathways lead to NF-κB induction (Shin et al., 2008). MyD88, TRIF, 
and Rip2 lead to the induction of MAPK signaling, including ERK1/2 and the kinase c-
Jun N-terminal kinase (JNK), which like NF-κB are also activated by other, unknown 
T4SS-dependent signals as well as in response to T4SS-dependent protein translation 
inhibition (Fontana et al., 2012; Shin et al., 2008). 
 
Toll-like receptor (TLR) signaling during L. pneumophila infection has been extensively 
studied both in vivo and in vitro. Although TLR4 is known to recognize bacterial LPS, 
LPS isolated from L. pneumophila is not a strong activator of TLR4 signaling (Archer and 
Roy, 2006; Lettinga et al., 2002). TLR2 is activated by outer wall components of L. 
pneumophila and TLR2 signaling leads to the production of many of the cytokines seen 
in response to L. pneumophila in vitro (Archer and Roy, 2006; Hawn et al., 2006; Shin et 
al., 2008). During L. pneumophila infection in vitro, TLR9 is stimulated upon recognition 
of CpG DNA motifs enriched in bacterial genomes (Archer et al., 2010; Newton et al., 
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2007). Although L. pneumophila expresses flagellin, determining a role for TLR5 
signaling in vitro is complicated by the absence of TLR5 on bone marrow-derived 
macrophages (Chandler et al., 1977; Hayashi et al., 2001; Means et al., 2003). In vivo, 
the absence of TLR5 does not alter the course of pulmonary infection (Archer et al., 
2010). In fact, mice deficient for either TLR2, TLR4, TLR5, or TLR9 demonstrate no 
defect or only a slight defect in controlling pulmonary L. pneumophila infection (Archer et 
al., 2010; Hawn et al., 2007). Even mice triply deficient in TLR2, 4, and 9 show a minimal 
defect in control. This is in stark contrast to the dramatic phenotype observed in MyD88-
deficient mice during infection, which are deficient in TLR signaling as well as IL-1 family 
signaling. No role has been determined for TLRs 3, 7, and 8 that recognize synthetic 
viral motifs. Likewise, no role has been investigated for TLRs 11, 12, or 13. In humans, 
certain mutations in TLR5 are associated with an increased prevalence of legionellosis 
(Hawn et al., 2003). This is in contrast to the phenotype of TLR5-deficient mice, 
indicating that the role of various immune pathways may differ between mouse models 
of L. pneumophila infection and clinical manifestations of disease (Hawn et al., 2007). 
 
Various intracellular PRRs are activated during WT L. pneumophila infection, but not 
with bacteria lacking a T4SS (Berrington et al., 2010; Neild and Roy, 2004; Shin and 
Roy, 2008). This T4SS-dependent intracellular activation is thought to be important for 
the distinction between virulent and avirulent L. pneumophila infection (Shin et al., 2008). 
Nod1 and Nod2, which signal via Rip2, are activated in response to the cell well 
components diaminopimelic acid (DAP) and muramyl dipeptide (MDP), respectively, in 
the cytosol of host cells (Girardin et al., 2003a; 2003b; Inohara et al., 2005). Deletion of 
Nod1 and Nod2 in vivo leads to different effects on pathogenesis; deletion of Nod1 
enhances disease, while deletion of Nod2 limits infection (Berrington et al., 2010; 
Frutuoso et al., 2010). RIG-I and MDA5 are activated by WT L. pneumophila infection 
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(Monroe et al., 2009). Both RIG-I and MDA5 signal via MAVS to induce the production of 
IFNβ. 
 
Additionally, intracellular pathways may sense the effects of the T4SS on host cell 
processes. Deletion of five of the effectors that inhibit protein translation alters the 
proinflammatory genes expressed in response to infection, notably the transcription of 
Gmcsf and Il23 (Fontana et al., 2011). Perturbations in mTOR signaling may partially 
drive the response to protein translation inhibition (Ivanov and Roy, 2013). Interestingly, 
deletion and manipulation of the known intracellular signaling pathways does not fully 
explain the difference in immune responses between virulent L. pneumophila and 
bacteria lacking a functional T4SS (Shin et al., 2008). Whether the host directly senses 
other, specific components of the T4SS or if other effects on the host cell, such as 
manipulation of ER-Golgi trafficking, activate the immune response is not known.  
 
G. Inflammasome activation during Legionella pneumophila infection 
The inflammasome is a large, multi-protein complex that forms in the cytosol of cells 
upon induction by various infectious or stress-induced signals. Many different 
inflammasomes have been characterized, but all inflammasome activation leads to the 
same downstream consequences: release of IL-1 family members and an inflammatory 
form of cell-death known as pyroptosis (Lamkanfi and Dixit, 2009; Moltke et al., 2013). 
Activation of the inflammasome is a two-step process. First, NF-κB induction leads to the 
translation of many of the components of the inflammasome, including the upstream 
NLRs and downstream caspases and IL-1 family members (Rathinam et al., 2012). 
NLRs are thought to be sensors that either directly or indirectly recognize stress or 
infectious components. Some of these NLRs, such as NLRC4, can then directly 
oligomerize and recruit caspase-1 (Broz et al., 2010). Others, such as NLRP3, require 
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the adaptor protein ASC to bridge the interaction between NLR and caspase 
(Mariathasan et al., 2006; Martinon et al., 2002). Both caspase-1 and caspase-11 are 
involved in inflammasome activation during L. pneumophila infection (Akhter et al., 2012; 
Case et al., 2009; Casson et al., 2013; Ren et al., 2006; Zamboni et al., 2006). Various 
NLRs are activated by infection and, importantly, inflammasome activation is exquisitely 
dependent on the T4SS (Casson et al., 2013). L. pneumophila lacking a functional T4SS 
fail to activate the inflammasome and no release of IL-1 family members or cell death is 
observed. In vivo, mice lacking caspase-1 and caspase-11 have increased bacterial 
burdens compared to the WT counterparts, but IL-1 family members can still be detected 
during infection, suggesting that other enzymes or pathways can mimic inflammasome 
activation in vivo (Barry et al., 2013; Casson et al., 2013). 
 
The earliest characterized inflammasome important for L. pneumophila infection is the 
Naip5/NLRC4 inflammasome (Derré and Isberg, 2004; Zamboni et al., 2006). Naip5, in 
conjunction with NLRC4, binds monomers of L. pneumophila flagellin (Kofoed and 
Vance, 2011). In C57BL/6 mice, this inflammasome is restrictive to growth and, thus, 
bacteria expressing flagellin are rapidly cleared in vivo and replicate poorly in 
macrophages derived from these mice in vitro (Molofsky et al., 2006; Ren et al., 2006). 
The discovery of Naip5 as an intracellular flagellin sensor occurred because although B6 
mice are restrictive, A/J mice and their macrophages are permissive for replication of 
WT L. pneumophila. A/J mice have a polymorphism in the Naip5 gene, resulting in a 
hypomorphic allele (Beckers et al., 1995; Dietrich et al., 1995; Diez et al., 2003; Wright 
et al., 2003). Either deletion of Naip5 from mice or deletion of the L. pneumophila 
flagellin gene flaA, results in restored replication in mice and macrophages (Coers et al., 
2007; Molofsky et al., 2006; Ren et al., 2006). As activation of this inflammasome 
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requires the T4SS, it is assumed the flagellin monomers are translocated into the cytosol 
of host cells, although this has never been fully demonstrated. 
 
In the absence of the Naip5/NLRC4/flagellin axis, inflammasome activation still occurs in 
a less robust and less rapid fashion (Case et al., 2009; 2013; Casson et al., 2013). Part 
of this remaining response is controlled by NLRP3, an inflammasome that requires the 
adaptor ASC (Case et al., 2013; Casson et al., 2013). What exactly NLRP3 senses 
during infection has not been described, although a variety of other signals, such as 
intracellular reactive oxygen species, uric acid crystal, extracellular ATP, and other 
cellular stressors lead to NLRP3 activation (Leemans et al., 2011). 
 
The interferon-inducible protein AIM2 recognizes cytosolic dsDNA, but is not normally 
activated by infection with L. pneumophila (Fernandes-Alnemri et al., 2009; Hornung et 
al., 2009; Roberts et al., 2009). The AIM2 inflammasome is induced, however, during 
infection with the SdhA mutant of L. pneumophila (Aachoui et al., 2013; Creasey and 
Isberg, 2012). It is not known how AIM2 ligands enter the cytosol, but it is assumed that 
cytosolic degradation of bacteria leads to the release of genetic content. 
 
More recently, caspase-11 has been demonstrated to be activated by L. pneumophila 
infection (Akhter et al., 2012; Barry et al., 2013; Case et al., 2013; Casson et al., 2013). 
The only known activator of caspase-11 is LPS as it can bind directly to caspase-11 in 
the absence of an NLR (Hagar et al., 2013; Kayagaki et al., 2013; Shi et al., 2014). 
Caspase-11 activation during L. pneumophila infection leads to the release of IL-1α and 
death of the host cell (Case et al., 2013; Casson et al., 2013). Interestingly, deletion of 
caspase-11 in murine macrophages ameliorates not only IL-1α release and cell death, 
but also diminishes IL-1β release, suggesting that caspase-11 activation feeds into 
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caspase-1-mediated responses (Case et al., 2013; Casson et al., 2013). It has not been 
directly shown that L. pneumophila LPS is the signal for caspase-11 activation. 
 
H. The cytokine response to Legionella pneumophila 
As a consequence of the various signaling cascades and PRRs activated by L. 
pneumophila, a variety of cytokines are produced during infection and many of these 
cytokines are critical for controlling and clearing infection. TNF, which binds the TNF 
receptor, is produced both in vitro and in vivo downstream of MyD88 and NF-κB 
signaling and is critical for limiting pulmonary infection (Brieland et al., 1998). In vitro, 
TNF restricts L. pneumophila growth in macrophages via an unknown mechanism 
(Coers et al., 2007). Importantly, human patients on TNF therapeutics that inhibit or limit 
TNF signaling are more susceptible to L. pneumophila infection (Aringer et al., 2009; 
Beigel et al., 2009; Jinno et al., 2009). 
 
IL-12 is produced in response to L. pneumophila infection and, like TNF, is protective 
(Brieland et al., 1998; 2000). IL-12 leads to the production of IFNγ (Hsieh et al., 1993). 
Mice deficient for IFNγ contain high bacterial burdens, although whether IFNγ deficiency 
is fatal in mice has not been reported (Heath et al., 1996; Spörri et al., 2006). IL-18 can 
lead to the production of IFNγ from natural killer (NK) cells during L. pneumophila 
infection; however, blocking IL-18 has no impact on bacterial burdens (Archer et al., 
2009; Brieland et al., 2000; Spörri et al., 2008). Blocking both IL-12 and IL-18 during 
infection leads to greater bacterial burdens than blocking either alone, suggesting 
synergy between these two cytokines (Brieland et al., 2000). 
 
Type I interferon and IL-6 are produced in response to L. pneumophila infection. In vitro, 
type I interferon restricts bacterial replication in macrophages; however, the effect of 
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deleting the type I interferon receptor, IFNAR, has a mild to absent phenotype during L. 
pneumophila infection (Ang et al., 2010; Plumlee et al., 2009). Type I interferon signaling 
may be more important in the absence of IFNγ signaling (Lippmann et al., 2011). A role 
for IL-6 has not been demonstrated during L. pneumophila infection, but is protective in 
other models of bacterial pneumonia (Jones et al., 2006; Sutherland et al., 2008; van der 
Poll et al., 1997). 
 
Beyond cytokines, chemokines are produced and play a role in controlling L. 
pneumophila infection. The chemokine KC is mildly protective during infection as it 
recruits neutrophils to the site of infection (Tateda et al., 2001b). Blockade of CXCR2, 
the receptor for KC, has a greater impact on infection than blocking KC alone (Tateda et 
al., 2001b). These data indicate a role for other chemokine ligands of CXCR2 during 
infection. Whether other chemokine receptors are critical for control of L. pneumophila 
infection, such as CCR2 or CXCR4 which recruit other immune cell types like 
monocytes, has not been investigated (Hasenberg et al., 2013). 
 
Both IL-1α and IL-1β are produced during L. pneumophila infection in vitro and in vivo. 
IL-1 signaling in vivo rapidly recruits neutrophils to the airway space during infection 
(Barry et al., 2013; Casson et al., 2013; LeibundGut-Landmann et al., 2011). Deletion of 
the IL-1R or IL-1α or antibody-mediated neutralization of IL-1 is deleterious to the host 
as evidenced by increased bacterial burdens and delayed clearance (Barry et al., 2013; 
Casson et al., 2013). Of note, there is a case study of a patient taking Anakinra, an IL-1 
antagonist, who became infected with L. pneumophila during therapy, suggesting a role 
for IL-1 in human as well as murine L. pneumophila infection (Scholtze et al., 2011). 
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I. The role of IL-1α and IL-1β during infection 
IL-1α and β are part of larger family of cytokines, known as the IL-1 family (Dinarello, 
1996). IL-1β and IL-1α are the founding members of the IL-1 family and were first 
described in the 1980s (Auron et al., 1984; March et al., 1985). Unlike other conventional 
cytokines, IL-1 family members are translated by cytosolic ribosomes and do not traffic 
through the ER-Golgi network (Stevenson et al., 1992). The transcription and translation 
of IL-1α and β, like many cytokines, require the induction of NF-κB signaling. Once 
translated, these cytokines exist in a cytosolic, inactive pool in their pro-forms. 
Translation of IL-1β and IL-1α alone does not lead to their activation. Instead, cleavage 
and activation of IL-1α and β require the activity of the inflammasome (Lamkanfi and 
Dixit, 2009). Cleavage is absolutely required for the release of IL-1β and its ability to bind 
the IL-1R (Black et al., 1988). IL-1α does not require cleavage for release and can bind 
and activate the IL-1R in either its full pro-form or mature form (Chen et al., 2007; 
Howard et al., 1991). The binding affinity to IL-1R is higher for pro- and mature IL-1α 
than for IL-1β (Symons et al., 1995).  
 
The IL-1R is expressed on a variety of cell types, including epithelial cells, endothelial 
cells, astrocytes, and T cells (Dinarello, 2013). The IL-1R itself is comprised of two 
chains. IL-1R1 physically binds the ligands IL-1α and IL-1β, as well as a non-signaling 
competitive antagonist IL-1Ra (Greenfeder et al., 1995). The second chain in the 
receptor is the IL-1Racp - a common chain that, in part, also forms the receptors for IL-
33 and IL-36. Signaling by the IL-1R requires MyD88, which is important for many of the 
TLRs (Weber et al., 2010). Induction of IL-1R signaling leads to the activation of NF-κB 
and MAPK pathways, ultimately leading to transcription of pro-inflammatory genes 
(Dinarello, 1996). IL-1R signaling on epithelial and endothelial cells leads to the 
production of IL-6 and various chemokines, including KC (Kirnbauer et al., 1989; 
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Nakamura et al., 1991; Schröder et al., 1990; Sironi et al., 1989). For immune cells, IL-1 
signaling on DCs leads to CD86 and CCR7 expression and IL-1 on T cells leads to the 
activation of T cells as well as Th17 skewing (Lichtman et al., 1988; Pang et al., 2013; 
Veldhoen et al., 2006). In vivo, injection of IL-1 leads to the rapid recruitment of 
neutrophils to the site of injection as well as the production of IL-6 and certain 
chemokines (Dinarello, 1996). IL-6 production induced by IL-1 leads to the induction of 
fever in humans and other mammals. Beyond immune responses, injection of IL-1β can 
diminish sexual receptivity in female, but not in male rats, highlighting the broad and 
systemic responses that IL-1 imparts on host organisms (Yirmiya et al., 1995). 
 
IL-1 and the IL-1R signaling have been shown to be protective in a variety of infectious 
models, including Salmonella enterica Typhimurium, Yersinia pseudotuberculosis, 
Staphylococcus aureus, and Mycobacterium tuberculosis, as well as others (Moltke et 
al., 2013). Interestingly, although IL-1α and IL-1β bind the same receptor, deletion of 
either IL-1α or IL-1β alone reduces resistance to M. tuberculosis in mice, suggesting a 
non-redundant role for the two cytokines (Mayer-Barber et al., 2011). In contrast, IL-1 
has been shown to be deleterious to the host in a number of infectious models as well as 
models of autoinflammatory disease (Dinarello, 1996). For example, IL-1β increases 
bacterial burden during Burkholderia pseduomallei infection (Ceballos-Olvera et al., 
2011). For autoinflammatory disorders, a role for IL-1 or inflammasome-associated 
genes has been demonstrated for cryopyrin-associated periodic syndrome, familial cold 
autoinflammatory syndrome, familial Mediterranean fever, rheumatoid arthritis, and 
others (de Jesus et al., 2015; Jesus and Goldbach-Mansky, 2014; Ting et al., 2006). 
Therapy for many of these syndromes and diseases relies on IL-1 antagonists, such as 
anakinra (Dinarello and van der Meer, 2013). Thus, IL-1 signaling is highly 
proinflammatory in a variety of settings. This inflammation can limit infection, but can 
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have pathological consequences Therefore, activation of the inflammasome and 
production of IL-1 family members is tightly regulated. 
 
J. Pulmonary immune responses 
The mammalian lung is a highly vascularized structure containing a variety of cell types. 
Alveolar macrophages are tissue resident macrophages of the lung. Many alveolar 
macrophages exist outside the body in the alveolar sacs (Hussell and Bell, 2014). During 
homeostasis they clear debris and surfactant from the airway space, facilitating 
respiration. Alveolar macrophages require GM-CSF for both their presence and function 
in the lung (Stanley et al., 1994). Their absence impairs lung function and in humans 
leads to a disease known as pulmonary alveolar proteinosis (Stanley et al., 1994). 
Although thought to be free of association with other cells, a subset of alveolar 
macrophages were recently shown to have intimate contact with the airway epithelium 
and were termed sessile alveolar macrophages (Westphalen et al., 2014). These 
macrophages are defined by their localization and no markers currently distinguish 
between these two types of alveolar macrophages. Alveolar macrophages express TLRs 
and are known to make cytokines such as TNF (Hussell and Bell, 2014). During 
Legionnaire’s disease, alveolar macrophages harbor L. pneumophila as evidenced by 
detection of Gram-negative bacteria by electron microscopy in human patients as well as 
by detection of GFP+ L. pneumophila in a murine model of infection (Horwitz and 
Silverstein, 1981; LeibundGut-Landmann et al., 2011). Alveolar macrophages, then, are 
thought to be the primary reservoir of L. pneumophila during pulmonary infection. 
Whether or not other cell types harbor L. pneumophila, however, has not been fully 
investigated. 
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There are two main types of epithelial cells in the mammalian lung, termed airway 
epithelial cells (AEC) type I and type II. AECIs physically perform the act of respiration 
by governing gas exchange (Borok et al., 2002; Johnson et al., 2002). AECIIs produce 
surfactant to lower surface tension facilitating gas exchange (Fleming et al., 1994). AECI 
and AECII cells are often connected via gap junctions, and signaling cascades initiated 
in one cell can migrate via these junctions to adjacent cells (Guo et al., 1999). In vitro, 
epithelial cells can be infected with L. pneumophila and the bacteria can adhere to the 
outside of epithelial cells, but no evidence for epithelial cell infection has been 
demonstrated in vivo (Maruta et al., 1998; Mody et al., 1993; Prashar et al., 2012). 
Epithelial cells produce chemokines, such as KC, during L. pneumophila infection, which 
are important to recruit immune cells to the site of infection (Tateda et al., 2001b). 
 
Neutrophils are not generally present in the lung tissue itself, but due to the vascularized 
nature of the tissue these cells are found in vessels throughout the tissue. Neutrophils 
are considered highly inflammatory cells in most tissues, including the lung (Mizgerd, 
2002). Neutrophils are often associated with tissue damage, as they are present at sites 
of damage to the epithelial barrier (Puljic et al., 2007). Neutrophils are recruited into the 
lung tissue and subsequently into the airway space itself by chemokines produced by 
epithelial cells during inflammation (Tateda et al., 2001a; 2001b). Neutrophils are highly 
bactericidal and L. pneumophila products can be detected in neutrophils during infection 
in vivo (LeibundGut-Landmann et al., 2011). Depletion of neutrophils with the antibody 
RB68C5 leads to a reduction in IL-18 and a subsequent decrease in IFNγ during L. 
pneumophila infection, ultimately leading to an increase in bacterial burdens (Spörri et 
al., 2008). Depletion with the RB68C5 clone, however, perturbs inflammatory 
monocytes, though the role of monocytes during infection has not been investigated on 
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its own (Daley et al., 2008). Thus, neutrophils are important for controlling infection, both 
for their ability to destroy live bacteria and their contribution to the cytokine milieu. 
 
Inflammatory monocytes and natural killer (NK) cells are recruited to the lung tissue 
during infection (LeibundGut-Landmann et al., 2011; Spörri et al., 2008). NK cells 
respond to IL-12 and IL-18 produced during infection and rapidly produce IFNγ that can 
be detected as early as two days post infection in mice (Archer et al., 2010). This IFNγ 
production is critical for control of infection. The role of inflammatory monocytes during L. 
pneumophila infection has not been investigated; however, inflammatory monocytes are 
important in other models of bacterial infection (Serbina et al., 2008). Inflammatory 
monocytes are capable of producing a wide array of proinflammatory cytokines, 
including TNF, IL-6, and IL-12 (Serbina et al., 2008). These cells are capable of 
differentiating into other cells types, including dendritic cells (DC) (León et al., 2004; 
Yang et al., 2014). Inflammatory monocytes have recently been demonstrated to be 
bactericidal in certain models of infection (Narni-Mancinelli et al., 2011). The recruitment 
of inflammatory monocytes during other infections, and in other tissues, is often 
dependent on the expression of CCR2 on the monocytes and production of CCR2 
ligands, such as CCL2, CCL7, and CCL12 in the infected site (Serbina et al., 2008). 
However, not all monocytes express CCR2; thus, certain subsets of monocytes are 
recruited independently of this pathway. 
 
A variety of cells exist in the mammalian lung, but their roles in controlling L. 
pneumophila infection have not been investigated. Conventional DCs (cDC) exist in the 
lung during both homeostasis and infection (Ang et al., 2010). In vitro, cDCs rapidly 
undergo apoptosis when infected with virulent L. pneumophila in a manner that is 
independent of the inflammasome, suggesting that they may not be able to harbor L. 
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pneumophila in vivo (Nogueira et al., 2009). Eosinophils, although well characterized for 
their ability to exacerbate the symptoms of asthma in the lung, have no demonstrated 
role in either controlling or worsening L. pneumophila infection (Busse and Sedgwick, 
1992; Stevens et al., 2007). B and T cells are recruited to the lung during infection and in 
other infectious models tertiary lymphoid structures (BALT) are formed weeks into 
pulmonary infection, which contain a large number of these cells (Sminia et al., 1989; 
Trunk and Oxenius, 2012). Antibody, and therefore B cell, responses are induced during 
L. pneumophila infection and passive transfer of immune sera protects mice from a low-
dose challenge model of infection (Weber et al., 2012). T cells have been demonstrated 
to produce both IFNγ and IL-17 during L. pneumophila infection, but the contribution of 
either of these responses has not been fully investigated (Trunk and Oxenius, 2012). 
 
K. Dissertation Aims 
It is evident, then, that rapid and robust immune responses are mounted in response to 
L. pneumophila infection both in vitro and in vivo. In vitro, this response is diminished, 
but still present, in response to L. pneumophila lacking a functional T4SS. In vivo, the 
immune response to T4SS-deficient L. pneumophila is nearly undetectable and these 
bacteria are rapidly cleared from the host. This leads to two conclusions. First, the 
proinflammatory immune response to L. pneumophila both in vitro and in vivo is greatly 
enhanced by the presence of the T4SS. And second, although the protein translation 
inhibition mediated by effectors of the T4SS should limit the immune response against L. 
pneumophila, an immune response is still mounted and is vital for control and ultimate 
clearance of bacteria from the host. This paradoxical T4SS-dependent immune 
response to L. pneumophila leads to two questions. Which cells are targeted by the 
T4SS of L. pneumophila during infection? And how does the immune system overcome 
the T4SS-dependent block in protein translation to produce cytokines? 
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In chapter 3 of this dissertation, I investigate the cell types targeted by the T4SS of L. 
pneumophila by using a fluorescence-based translocation assay. I find that alveolar 
macrophages and neutrophils are the primary reservoir for L. pneumophila during 
pulmonary infection as they are both targeted by the T4SS and contain viable L. 
pneumophila. Although the T4SS can actively inject dendritic cells in vitro, I see no 
injection into dendritic cells in vivo. Likewise, I see no injection into alveolar epithelial 
cells. Surprisingly, although only a small percentage of neutrophils harbor viable L. 
pneumophila, neutrophils are the largest reservoir of viable bacteria in vivo. 
 
In chapter 4, I investigate the ability of injected cells and uninjected, bystander cells to 
produce proinflammatory cytokines in response to infection by combining our β-
lactamase (BlaM)-based assay with intracellular cytokine staining. Injected cells are able 
to produce IL-1α and β, but are poor producers of the cytokines TNF, IL-6, IL-12p40, and 
do not increase expression of CD86. Instead, cells not targeted by the T4SS during 
infection, including non-targeted alveolar macrophages and neutrophils, produce TNF in 
response to L. pneumophila infection in vivo and increase expression of CD86. 
Importantly, this TNF production and CD86 expression is partially dependent on IL-1R 
signaling, suggesting that the IL-1 produced by alveolar macrophages and neutrophils 
during infection is critical for the response of uninfected, bystander cells. Together, these 
data suggest a coordinated effort between cells that harbor viable L. pneumophila during 
infection and uninfected, bystander cells to produce a successful immune response in 
spite of pathogenic manipulation of host cell processes. Part of the communication 
between infected and uninfected cells depends on the production of IL-1α and β. This 
signaling pathway may be more broadly applicable to other infections, as IL-1 is 
produced in response to variety of bacterial pathogens and aids in bacterial clearance. 
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Figure 1-1. Bacterial pathogens inhibit host cell signaling and protein translation during 
infection. A number of bacterial pathogens encode virulence factors that inhibit host cells 
processes. NF-κB signaling is inhibited by virulence factors from Escherichia coli, 
Yersinia spp., and Shigella flexneri. MAPK signaling is also inhibited by proteins from 
Yersinia spp. and S. flexneri as well as Vibro parahaemolyticus and Bacillis anthracis. 
Downstream of receptor signaling Shigella dysenteriae, Pseudomonas aeruginosa, 
Corynebacterium diphtheria, and Legionella pneumophila encode virulence factors that 
inhibit host protein synthesis. Despite this, immune responses are still mounted against 
these pathogens as evidenced by proinflammatory cytokine production, indicating that 
hosts have mechanisms to bypass pathogenic manipulation. 
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Figure 1-2. Legionella pneumophila activates multiple immune pathways, but inhibits 
protein synthesis in infected cells. Infection with Legionella pneumophila activates 
multiple signaling pathways, leading to the induction of NF-κB and MAPK signaling. 
These pathways induce the transcription of proinflammatory genes. The T4SS effectors 
Lgt1, Lgt2, Lgt3, SidI, SidL, Pkn5, and Lpg1489 block the translation of these proteins; 
yet, TNF, IL-6, and IL-12 are produced during L. pneumophila infection. In tandem, 
bacterial products in the cytosol of infected cells activates the inflammasome, leading to 
the processing of mature IL-1 and death of the host cell. The coordination of all these 
events is poorly characterized.  
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CHAPTER 2 
MATERIALS AND METHODS 
 
Ethics statement 
All experiments performed in this study were done so in accordance with the Animal 
Welfare Act (AWA), the recommendations in the Guide for the Care and Use of 
Laboratory Animals of the National Institutes of Health. The Institutional Animal Care and 
Use Committee of the University of Pennsylvania approved all procedures (protocols 
#803465, #803459, and #804928). 
 
Bacterial strains and plasmids 
All experiments used Legionella pneumophila serogroup 1 strains. For in vitro studies, 
macrophages, dendritic cells, and epithelial cells were infected with Lp02 (rpsL, hsdR, 
thyA), a thymidine auxotroph derived from strain Lp01, or ΔdotA or ΔflaA isogenic 
mutant strains (Berger and Isberg, 1993). Certain experiments also used strains of L. 
pneumophila with deletions in Lgt1, Lgt2, Lgt3, SidI, and SidL on the Lp02 background 
(WTΔ5) or L. pneumophila with deletions in Lgt, Lgt2, Lgt3, SidI, SidL, Pkn5, and 
Lpg1489 on the ΔflaA background (Δ7ΔflaA) (Barry et al., 2013; Fontana et al., 2011). 
For in vivo studies, mice were infected with JR32-derived (rpsL, hsdR) ΔdotA or ΔflaA 
isogenic mutant strains (Marra and Shuman, 1989; Ren et al., 2006). For in vivo 
experiments requiring cell sorting, the aforementioned Lp02 strains were used. For in 
vitro and in vivo studies L. pneumophila was cultured on charcoal yeast extract agar 
containing 6.25µg/mL chloramphenicol for 48 hours at 37°C prior to infection (Feeley et 
al., 1979; Neild et al., 2005). For studies requiring motile L. pneumophila, 48 hour 
cultures grown on CYE agar were grown overnight in AYE broth containing 
chloramphenicol with shaking at 37°C until >50% of the bacteria were observed to be 
30	  
motile by light microscopy. Plasmids encoding M45 tagged β-lactamase-RalF fusion 
protein or M45-tagged β-lactamase were generated as follows. Briefly, the pJB1806 
plasmid (RSF1010 ori, tdΔI, Ampr, Cmr) was first modified by cloning the icmR promoter 
and M45 epitope tag into the EcoRI and BamHI sites (Bardill et al., 2005). The mature 
TEM-1 β-lactamase gene (BlaM) was then amplified from a Y. pseudotuberculosis 
YopE-BlaM-encoding plasmid using primers that introduced a 5’ BglII site (5’-
AATAAGATCTTGCACCCAGAAACGCTGGTG-3’) and 3’ BamHI site (5’-
GCCTCACTGATTAAGCATTGGGGGATCCAATA-3’ 
) (Brodsky and Medzhitov, 2008). The resulting PCR product was digested with BglII and 
BamHI and cloned into the BamHI site of the pJB1806 PicmR:M45 plasmid to create a 
plasmid encoding M45-tagged β-lactamase. To generate the plasmid encoding a 
translational fusion of M45-β-lactamase-RalF, RalF was amplified from Lp01 genomic 
DNA using primers that introduced BamHI sites at the 5’ and 3’ ends (5’-
AATAGGATCCGGCATCCAGAAATTGAAAAAGCCC-3’) and (5’-
GAAAAAGGTAGACAATTAAAATTTTAAGGATCCAATA-3’). The resulting PCR product 
was digested with BamHI and cloned into the BamHI site downstream of gene encoding 
M45-BlaM. The resulting plasmids were then electroporated into L. pneumophila and 
transformed colonies were selected for with chloramphenicol (Marra et al., 1992). 
 
Mice 
All mice were purchased from Jackson Laboratories. Mice were maintained in 
accordance with the guidelines of the University of Pennsylvania Institutional Animal Use 
and Care Committee. For infections, 8-12 week old male and female mice were 
anesthetized by intraperitoneal injection of a ketamine/xylazine/PBS solution at a dose of 
100mg/kg ketamine and 10mg/kg xylazine. Mice were then infected intranasally with 
40µl of a bacterial suspension containing 1-5x106 CFU L. pneumophila or PBS vehicle 
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control. At the indicated time points after infection, mice were sacrificed. To isolate lung 
airway cells, bronchoalveolar lavage was performed 3-5 times with 1mL of cold PBS 
each time. Lungs were then excised and digested for 30 minutes at 37°C with occasional 
shaking in 5mL of PBS containing 5% FBS, 250U/mL of collagenase IV (Worthington 
Biochem), and 20U/mL DNAse I (Roche). Lungs were then mechanically homogenized 
and a single-cell suspension was obtained. To determine bacterial burden, lungs were 
mechanically homogenized in sterile, distilled H2O and a portion of the lysate was spread 
onto CYE plates containing either chloramphenicol or streptomycin. 
 
Antibody-mediated neutralizations and depletions 
All antibodies were administered by intraperitoneal injection in 500µl PBS. For IL-1 
antibody neutralizations 16 hours prior to infection, mice were given 200µg of either 
isotype antibody (hamster IgG), antibody against IL-1α (α-IL-1α) (ALF-161), IL-1β (α-IL-
1β) (B122), or both (BioXcell).  
 
Cell culture 
For macrophages, C57BL/6 mouse bone marrow cells were differentiated in RPMI 
containing 30% L929 cell supernatant and 20% FBS at 37°C, 5% CO2 in a humidified 
incubator. The macrophages were replated in RPMI containing 15% L929 cell 
supernatant and 10% FBS (Casson et al., 2013). For dendritic cells, bone marrow cells 
were differentiated in RPMI containing 10% FBS, 50µM β-mercaptoethanol, 2mM L-
glutamine, and 20ng/mL GM-CSF (Peprotech) (Inaba et al., 1992). Semi-adherent 
dendritic cells were then isolated and replated in medium lacking GM-CSF. A549 cells 
and NIH/3T3 cells (ATCC) were cultured in DMEM containing 10% FBS 
(Wickremasinghe et al., 1999). For infections, cells were treated with 10-100ng/mL LPS 
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from E. coli strain 055:B5 (Sigma), 0.4µg/mL PAM3CSK4, 10µl of bacterial suspension, 
or 10µL of PBS vehicle control. 
 
Isolation of inflammatory monocytes and alveolar macrophages 
Alveolar macrophages were harvested from the airways of mice by bronchoalveolar 
lavage in 5 x 1mL cold PBS. For intracellular cytokine staining, cells were centrifuged, 
counted, and resuspended at 10,000 cells per well in 150µl DMEM + 10% FBS. 
Inflammatory monocytes were isolated from the bone marrow of mice using a magnetic 
negative selection kit (Miltenyi). Inflammatory monocytes were assayed for purity post 
selection and were consistently 90-95% CD45+, Ly6Chi, Ly6G-, CD11bint to CD11bhi. For 
intracellular cytokine staining, inflammatory monocytes were resupsended at 30,000 
cells per well in 150µl DMEM with 10% FBS. 
 
Flow cytometry, fluorescence-based imaging flow cytometry, and cell sorting 
For in vitro experiments, infected cells were lifted and loaded with CCF4-AM (Invitrogen) 
per the manufacturer’s instructions. Cells were then washed and treated with Live/Dead 
Fixable Dead Cell Stain (Invitrogen). Bone marrow-derived dendritic cells were stained 
with antibodies specific for CD11c and MHCII (eBioscience). To stain for intracellular L. 
pneumophila, cells were fixed with BD Cytofix, permeabilized with BD Phosflow Perm 
Buffer III (BD Biosciences), and then stained with a rabbit polyclonal antibody against L. 
pneumophila followed by a rabbit-specific secondary antibody tagged to a fluorophore 
(Invitrogen). For in vivo studies, lung and airway cells were loaded with CCF4-AM and 
treated with the Live/Dead stain. Cells were then stained with antibodies specific for the 
cell surface antigens CD45, CD11c, Ly6G, Ly6C, NK1.1 (BioLegend), MHCII, CD19, 
CD3ε, CD31, CD326 (eBioscience), Siglec F, CD11b, and Ter119 (BD Biosciences). 
Data were collected on a LSR II flow cytometer (BD Biosciences) and post-collection 
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data were analyzed using FlowJo (Treestar). For fluorescent imaging experiments, data 
and images were collected on an Amnis ImageStreamX Mark II and data were analyzed 
using IDEAS software (EMD Millipore), Cells were gated on live singlets that had 
retained the CCF4-AM dye. Cell sorting experiments were performed on a FACSAria II 
flow cytometer (BD Biosciences). 
 
Intracellular staining 
For in vitro experiments, infected cells were treated with 10µg/mL brefeldin A with or 
without 2µM monensin (Sigma) three hours prior to harvest. To stain for intracellular 
cytokines cells were fixed with BD Cytofix/Cytoperm (BD Biosciences), and then stained 
with antibodies specific for IL-6 (BioLegend), TNF, IL-1α and IL-1β (eBioscience). For in 
vivo studies, lung and airway cells were resuspended in RPMI or DMEM containing 10% 
FBS and 10µg/mL brefeldin A for 3 hours. Intracellular staining was performed as 
described above. Data were collected on a LSR II flow cytometer (BD Biosciences) and 
post-collection data were analyzed using FlowJo (Treestar). Cells were gated on live 
singlets that had retained the CCF4-AM dye. Cell sorting experiments were performed 
on a FACSAria II flow cytometer (BD Biosciences). 
 
IL-1 Stimulation 
For treatment of cells with IL-1, mature recombinant IL-1α, IL-1β, or IL-1α and IL-1β 
(eBioscience) combined were added to cells at various concentrations. For intracellular 
staining of BMDCs, inflammatory monocytes, and alveolar macrophages, IL-1 was 
added at 100ng/mL for 6 hours with BFA added 3 hours prior to harvest. BMDCs were 
stained for CD11c, MHCII, and CD86. BMDCs were then fixed and stained for TNF. 
Inflammatory monocytes were stained for CD45, Ly6C, Ly6G, CD11b, Ter119, CD86 
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and then fixed and stained for TNF. Alveolar macrophages were fixed and then stained 
for TNF. 
 
ELISA 
Harvested supernatants from cultured cells or BAL were assayed using capture and 
detection antibodies specific for IL-1α, IL-6, TNF, IL-12p70 (BioLegend), KC (R&D 
system), and IL-12p40 (BD Biosciences). 
 
RT-PCR 
Sorted bone marrow-derived macrophages were centrifuged and resuspended in RLT 
lysis buffer and RNA was isolated using an RNeasy kit as per kit’s protocol (Qiagen). 
RNA was then reverse transcribed into cDNA using Superscript II reverse transcriptase 
(Invitrogen). Quantitative PCR was then performed using the prepared cDNA with 
primers for Il1b (5’-GCA ACT GTT CCT GAA CTA AAC T-3’, 5’-ATC TTT TGG GGT 
CCG TCA ACT-3’), Il1a (5’-GCA CCT TAC ACC TAC CAG AGT-3’, 5’-TGC AGG TCA 
TTT AAC CAA GTG G-3’), Il6 (5’-GAC TTC CAT CCA GTT GCC TTC TTG G-3’, 5’-CCA 
GTT TGG TAG CAT CCA TCA TTT CT-3’), Tnf (5’-GAC GTG GAA CTG GCA GAA 
GAG-3’, 5’-TTG GTG GTT TGT GAG TGT GAG-3’), or the housekeeping gene Hprt (5’-
GTT GGA TAC AGG CCA GAC TTT GTT G-3’,5’-GAG GGT AGG CTG GCC TAT AGG 
CT-3’). Data were analyzed using by comparing the CT values obtained for each reaction 
and then comparing them with the appropriate samples’ housekeeping gene to 
determine relative expression. 
 
Immunoblot analysis 
Legionella pneumophila expressing the appropriate reporter plasmids were harvested 
from a two-day heavy patch and lysed. Lysates were then subjected to SDS-PAGE, 
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transferred to PVDF membrane, and probed with an anti-M45 epitope monoclonal 
antibody (Obert et al., 1994). 
 
Statistical analysis 
Plotting of data and statistical analysis were performed using Graphpad Prism software. 
Statistical significance was determined using the unpaired, two-tailed Student’s t test or 
one-way ANOVA with Tukey post-test. Differences were considered significant if the p 
value was <0.05. 
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CHAPTER 3 
ALVEOLAR MACROPHAGES AND NEUTROPHILS ARE THE PRIMARY 
RESERVOIRS FOR LEGIONELLA PNEUMOPHILA AND MEDIATE CYTOSOLIC 
SURVEILLANCE OF TYPE IV SECRETION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter appeared as a published peer-reviewed article titled “Alveolar Macrophages 
and Neutrophils Are the Primary Reservoirs for Legionella pneumophila and Mediate 
Cytosolic Surveillance of Type IV Secretion” by Alan M. Copenhaver, Cierra N. Casson, 
Hieu T. Nguyen, Thomas C Fung, Matthew M. Duda, Craig R. Roy, and Sunny Shin. 
Infection and Immunity, 2014. 
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Abstract 
Legionella pneumophila, an intracellular pathogen responsible for the severe pneumonia 
Legionnaires’ disease, uses its dot/icm-encoded type IV secretion system (T4SS) to 
translocate effector proteins that promote its survival and replication into the host cell 
cytosol. However, by introducing bacterial products into the host cytosol, L. pneumophila 
also activates cytosolic immunosurveillance pathways, thereby triggering robust 
proinflammatory responses that mediate control of infection. Thus, the pulmonary cell 
types that L. pneumophila infects may act not only as an intracellular niche that 
facilitates its pathogenesis, but also contribute to the immune response against L. 
pneumophila. The identity of these host cells remains poorly understood. Here, we 
developed a strain of L. pneumophila producing a fusion protein consisting of β-
lactamase fused to the T4SS-translocated effector RalF, which allowed us to track cells 
injected by the T4SS. Our data reveal that alveolar macrophages and neutrophils are 
both the primary recipients of T4SS-translocated effectors and harbor viable L. 
pneumophila during pulmonary infection of mice. Moreover, both alveolar macrophages 
and neutrophils from infected mice produced TNF and IL-1α in response to T4SS-
sufficient, but not T4SS-deficient, L. pneumophila. Collectively, our data suggest that 
alveolar macrophages and neutrophils are both an intracellular reservoir for L. 
pneumophila and a source of proinflammatory cytokines that contribute to the host 
immune response against L. pneumophila during pulmonary infection. 
 
Introduction 
Legionella pneumophila is a Gram-negative bacterium found ubiquitously in fresh water 
environments, where it is often found in association with its natural host, protozoan 
amoebae (Fields, 1996). L. pneumophila has recently become a human pathogen due to 
modern technologies, such as cooling towers and air conditioners, which can aerosolize 
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fresh water contaminated with L. pneumophila (Fraser et al., 1977; McDade et al., 1977; 
Phin et al., 2014). Humans can then inhale these contaminated droplets, thus allowing L. 
pneumophila to gain access to the pulmonary airway. L. pneumophila infection can lead 
to a severe bacterial pneumonia known as Legionnaires’ disease (Fraser et al., 1977), 
with mortality rates approaching 30% (Domínguez et al., 2009). 
 
Once in the lung, L. pneumophila encounters a specialized subset of pulmonary 
phagocytes called alveolar macrophages (Chandler et al., 1977). Following 
phagocytosis, the Legionella-containing phagosome avoids endocytic maturation and 
bacterial degradation and is converted into an ER-derived vacuole that supports 
bacterial replication (Shin and Roy, 2008). To establish infection, L. pneumophila utilizes 
its type IV secretion system (T4SS), encoded by the dot/icm genes, to translocate 
approximately 300 effector proteins into the host cell cytosol (Berger and Isberg, 1993; 
Ensminger and Isberg, 2009; Hubber and Roy, 2010; Marra et al., 1992; Nagai, 2002; 
Roy et al., 1998; Segal et al., 1998; Vogel et al., 1998). Many of these effector proteins 
are thought to be involved in recruiting ER-derived vacuoles to the Legionella-containing 
vacuole or preventing endocytic maturation (Hubber and Roy, 2010). Other effector 
proteins modulate host cell processes such as autophagy or host protein synthesis 
(Barry et al., 2013; Belyi et al., 2006; 2008; Choy et al., 2012; Shen et al., 2009). These 
virulence activities ultimately prevent destruction of L. pneumophila and allow for its 
replication within host cells. The T4SS is essential for the ability of L. pneumophila to 
survive and replicate within host cells, as L. pneumophila mutants lacking a functional 
T4SS do not replicate and reside in phagosomes that mature along a canonical 
endocytic pathway (Berger and Isberg, 1993; Roy et al., 1998). 
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While the Dot/Icm T4SS is essential for L. pneumophila to survive intracellularly and to 
cause disease, cytosolic immune surveillance systems activate host defense responses 
to T4SS activity that are critical for the control of L. pneumophila infection (Shin, 2012). 
For example, the NAIP5/NLRC4 inflammasome detects T4SS-dependent delivery of 
flagellin, leading to the caspase-1-dependent secretion of IL-1 family cytokines and 
pyroptotic cell death (Lightfield et al., 2008; Molofsky et al., 2006; Ren et al., 2006). 
Cytosolic detection of T4SS activity is also required for the robust secretion of 
inflammasome-independent cytokines, such as TNF (Fontana et al., 2011; Shin et al., 
2008; Spörri et al., 2006). The IL-1 of family cytokines and TNF are critical for host 
defense against L. pneumophila (Barry et al., 2013; Brieland et al., 1995; Casson et al., 
2013; LeibundGut-Landmann et al., 2011). Thus, the cells that interact with L. 
pneumophila in the lung and receive T4SS-translocated effectors may have a dual role 
during in vivo infection, in that they can enable intracellular survival of the pathogen and 
also contribute directly to the immune response by detecting T4SS-translocated 
products. However, the identities of the pulmonary cell types that interact with L. 
pneumophila and receive T4SS-translocated effectors are poorly understood.  
 
Alveolar macrophages are thought to be the primary cell type infected by L. pneumophila 
and to support bacterial replication in vivo (Nash et al., 1984). However, it is unknown 
whether other immune phagocytes in the lung, such as neutrophils, inflammatory 
monocytes, or dendritic cells, may also receive T4SS-translocated effectors and 
contribute to the immune response or support L. pneumophila survival. Previous studies 
have demonstrated that in addition to alveolar macrophages, L. pneumophila can be 
detected in neutrophils during pulmonary infection (LeibundGut-Landmann et al., 2011). 
Neutrophils are thought to be highly bactericidal, and their presence in the lung and 
airway space during pulmonary L. pneumophila infection correlates with lower bacterial 
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burden (Barry et al., 2013; Casson et al., 2013; Nauseef, 2007; Tateda et al., 2001a; 
2001b). Whether L. pneumophila can survive within neutrophils and translocate T4SS 
effectors into these cells during pulmonary infection is unknown. L. pneumophila can be 
taken up by a wide variety of cell types in vitro, such as neutrophils, bone marrow-
derived dendritic cells, type I and type II alveolar epithelial cells, endothelial cells, and 
plasmacytoid dendritic cells (Ang et al., 2010; Horwitz and Silverstein, 1981; Maruta et 
al., 1998; Mody et al., 1993; Neild and Roy, 2003). However, the efficiency of L. 
pneumophila replication within these cell types varies greatly, and whether these cell 
types are injected by the T4SS or productively infected in vivo is unknown. We thus 
decided to investigate which cell types receive T4SS-translocated effectors and 
therefore may support L. pneumophila survival and contribute to cytosolic 
immunosurveillance during pulmonary infection. 
Using a FRET-based reporter of T4SS translocation, we were able to detect effector 
translocation into macrophages, dendritic cells, and airway epithelial cells in vitro. We 
also demonstrate that only T4SS-injected cells contain viable L. pneumophila, whereas 
infected cells that have not received T4SS effectors do not contain viable bacteria. In 
vivo, alveolar macrophages and neutrophils in the airway space and lung tissue were the 
primary recipients of T4SS-translocated effectors and harbored viable bacteria. 
Consistent with the critical role of immune sensing of T4SS activity in triggering host 
cytokine production, alveolar macrophages and neutrophils from mice infected with 
T4SS-competent L. pneumophila, but not T4SS-deficient bacteria, secreted the 
cytokines TNF and IL-1α, which are known to be important for immune-mediated 
clearance of infection (Brieland et al., 1995; Casson et al., 2013; LeibundGut-Landmann 
et al., 2011). We did not observe T4SS-mediated injection into other lung cell 
populations, including airway epithelial cells and dendritic cells, suggesting that these 
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cells are neither a primary intracellular niche for L. pneumophila, nor do they directly 
participate in cytosolic immunosurveillance of T4SS activity during lung infection. 
Collectively, our data indicate that alveolar macrophages and neutrophils play a dual role 
as both an intracellular niche and immune mediator during pulmonary L. pneumophila 
infection. 
Results 
A reporter system tracks translocation of type IV secretion system effectors by 
Legionella pneumophila into mammalian cells 
L. pneumophila uses its type IV secretion system (T4SS) to translocate effector proteins 
into the cytosol of host cells. To track this translocation, we constructed a plasmid in 
which the well-characterized L. pneumophila icmR promoter  drives transcription of a 
gene encoding a translational fusion of the mature TEM-1 BlaM and the well-
characterized T4SS  effector protein RalF and introduced this plasmid into L. 
pneumophila (Figure 3-1A & B) (Gal-Mor et al., 2002; Knapp et al., 2003; Zlokarnik et al., 
1998). We chose RalF because it is translocated into the cytosol of  infected cells 
immediately following intimate interaction of L. pneumophila with host cells (Nagai et al., 
2005; Ninio and Roy, 2007). Following infection of host cells by bacterial strains 
expressing the BlaM-RalF fusion protein, the enzymatic activity of translocated BlaM-
RalF was detected in host cells by means of the membrane-permeable BlaM substrate 
CCF4-AM (Zlokarnik et al., 1998). CCF4-AM consists of coumarin joined to fluorescein 
by a β-lactam ring. When excited at 409nm, fluorescence resonance energy transfer 
(FRET) between coumarin and fluorescein results in green fluorescence emission at 
518nm. T4SS-injected BlaM will cleave the CCF4-AM substrate in the host cytosol and 
eliminate FRET, thus resulting in blue fluorescence emission at 447nm.  
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We generated L. pneumophila strains expressing either BlaM or BlaM-RalF and infected 
C57BL/6 bone marrow-derived macrophages (BMDM) with these strains for 8 hours. 
Following infection, the cells were loaded with CCF4-AM and analyzed by flow cytometry 
to determine whether blue fluorescence emitted by cleaved CCF4-AM was detected 
(Figure 3-1C). Approximately 20-25% of macrophages infected with BlaM-RalF-
expressing WT L. pneumophila and L. pneumophila lacking flagellin (ΔflaA), which 
evade NAIP5 inflammasome responses, were positive for blue fluorescence resulting 
from cleaved CCF4-AM, but not following infection with strains lacking a functional T4SS 
(ΔdotA). This indicates that CCF4-AM is efficiently cleaved only by BlaM-RalF 
translocated by T4SS-sufficient bacteria and that BlaM-RalF remaining within bacteria 
does not generate a detectable signal in this assay. The frequencies of injected cells in 
WT and ΔflaA L. pneumophila infections were comparable, although the frequency of 
injection was consistently lower in WT infections (Figures 3-1C, 3-2A, & 3-5A). The 
robust detection of injection by WT L. pneumophila is surprising considering that a 
higher percentage of vacuoles containing WT L. pneumophila fail to avoid rapid 
endocytic maturation and that flagellin induces NAIP5-dependent cell death in C57BL/6 
macrophages (Amer and Swanson, 2005; Amer et al., 2006; Byrne et al., 2013; Molofsky 
et al., 2006; Ren et al., 2006). Following infection with L. pneumophila strains expressing 
BlaM alone, we found that a much lower percentage of macrophages became positive 
for blue CCF4-AM fluorescence compared to macrophages infected with L. pneumophila 
expressing BlaM-RalF (Figure 3-1C). Importantly, this small percentage of CCF4-AM 
positive cells was still dependent on infection with T4SS-sufficient bacteria, suggesting 
that BlaM lacking a canonical T4SS signal sequence may be inefficiently delivered into 
the host cytosol by the T4SS. 
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T4SS-injected host cells contain viable Legionella pneumophila. 
The T4SS is essential for the survival of L. pneumophila within host cells. To determine 
whether cells injected with BlaM-RalF contain L. pneumophila, we infected BMDMs with 
these reporter strains and loaded the cells with CCF4-AM. After loading, the 
macrophages were fixed, permeabilized, and stained with an antibody specific for L. 
pneumophila (Figure 3-2A). Infection with all three strains (WT, ΔdotA, ΔflaA) of L. 
pneumophila resulted in macrophages staining positive for the presence of bacteria. 90-
100% of cells that were positive for BlaM-RalF injection were also positive for L. 
pneumophila staining in both the WT and ΔflaA strains. With both strains, we detected a 
subset of cells that was positive for L. pneumophila but translocation of BlaM-RalF was 
not within a detectible range, revealing heterogeneity in BlaM-RalF translocation at the 
single cell level. The percentage of cells positive for L. pneumophila but negative for 
BlaM-RalF translocation could result from bacteria that failed to successfully translocate 
T4SS effectors into the host cell, either because they were non-viable, were not in the 
transmissive phase, or failed to efficiently evade rapid phagosomal maturation.  
 
To determine whether the L. pneumophila associated with injected or uninjected 
macrophages were intact or degraded, we infected macropohages with our reporter 
strains of L. pneumophila and analyzed these macrophages with fluorescence-based 
imaging flow cytometry (Figure 3-2B and Figures 3-3A). The majority of macrophages 
infected with the ΔdotA strain showed dim L. pneumophila staining, with multiple small 
puncta present per cell (Figure 3-2C). Because the ΔdotA mutants are unable to evade 
endocytic maturation due to their lack of a functional T4SS, punctate staining could 
result from bacteria that were degraded. Alternatively, punctate staining could represent 
uninfected cells that had phagocytosed bacterial debris. When we infected macrophages 
with ΔflaA L. pneumophila encoding a functional T4SS, we again could identify T4SS-
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injected and uninjected cells. Many of the uninjected cells stained positive for 
intracellular L. pneumophila (Figure 3-3B) as determined by analysis of the images 
obtained of infected cells using fluorescent-based imaging flow cytometry, but the 
majority of these cells exhibited dim, punctate staining similar to the staining seen for 
ΔdotA-infected macrophages (Figure 3-2B & C). This may represent cells containing 
bacteria that had not successfully evaded endocytic maturation or uninfected cells that 
had phagocytosed bacterial debris. In contrast, the majority of injected cells showed a 
single bright punctum of L. pneumophila staining, indicating the presence of an intact 
bacterium that had not been transported to a hydrolytic compartment.  
 
To test whether injected macrophages contain viable L. pneumophila, we sorted infected 
macrophages that were either positive or negative for the cleaved CCF4-AM signal, 
lysed the macrophages, and enumerated bacterial CFUs in these distinct cell 
populations (Figure 3-2D). T4SS-injected cells recovered from a ΔflaA L. pneumophila 
infection contained the vast majority (nearly 6 bacteria for every injected BMDM) of 
viable L. pneumophila as determined by CFU count. Uninjected cells from the same 
infection contained a minimal number of viable L. pneumophila (less than 1 bacterium for 
each uninjected BMDM), comparable to the number of viable bacteria recovered from a 
ΔdotA infection. To exclude the possibility that the uninjected cells contained viable L. 
pneumophila that lost the BlaM-RalF reporter plasmid encoding chloramphenicol 
resistance, we also plated cell lysates in the presence or absence of chloramphenicol 
(Figure 3-4A). The CFUs obtained on plates with and without chloramphenicol were 
indistinguishable, suggesting that the plasmid is stably maintained during in vitro 
infection in the absence of antibiotics. Collectively, our data indicate that viable bacteria 
are associated primarily with cells that have received translocated BlaM-Ralf, whereas 
uninjected cells are either not infected or contain non-viable bacteria. 
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Translocation by the type IV secretion system can be detected in dendritic cells 
and alveolar epithelial cells in vitro 
L. pneumophila can infect a variety of cell types in vitro, including dendritic cells and 
airway epithelial cells (Maruta et al., 1998; Mody et al., 1993; Neild and Roy, 2003). We 
thus examined whether T4SS-mediated translocation into these cell types could be 
detected using the β-lactamase reporter system. At a given MOI, as compared to 
infected BMDMs, we detected a much lower frequency of T4SS-mediated injection into 
bone marrow-derived dendritic cells (BMDCs) infected with WT or ΔflaA L. pneumophila 
(Figure 3-5A & B). We also infected A549 cells, an alveolar epithelial cell line, and 
detected a low frequency of injection into these cells (Figure 3-5C). 
 
Other researchers have noted an increase in bacterial uptake by host cells when L. 
pneumophila is grown under conditions that promote bacterial motility (Ren et al., 2006). 
Indeed, infection of macrophages with motile L. pneumophila resulted in a large increase 
in the frequency of injected macrophages, as the percentage of injected cells increased 
from 10% to more than 80% (Figure 3-6B). In contrast, in A549 cells, we did not observe 
an increase in injection regardless of bacterial motility in that 1.3% of cells infected with 
non-motile or motile L. pneumophila were injected (Figure 3-6A). For all cell types, the 
percentage of cells injected by the T4SS of L. pneumophila increased over time (Figure 
3-5). In all instances, cleaved CCF4-AM signal required expression of a functional T4SS, 
suggesting that the β-lactamase reporter operates in a T4SS-dependent manner in a 
variety of cell types. As we observed more robust injection into macrophages and 
dendritic cells than into non-phagocytic alveolar epithelial cells, these data suggest that 
both increased cell contact and efficient uptake by professional phagocytes contribute to 
the ability of L. pneumophila to efficiently translocate effector proteins. 
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Legionella pneumophila translocates bacterial effectors into alveolar 
macrophages and neutrophils during pulmonary infection 
Our data suggest that the L. pneumophila T4SS can translocate effectors into alveolar 
epithelial cells, dendritic cells, and macrophages during in vitro infection.  During 
pulmonary infection, replicating L. pneumophila can be detected in alveolar 
macrophages (Nash et al., 1984), indicating that alveolar macrophages receive T4SS-
translocated effectors. However, whether alveolar epithelial cells, dendritic cells, and 
other cell types receive T4SS-translocated effectors in vivo has not been investigated. 
To identify the cells that receive translocated effectors during a permissive model of in 
vivo infection, we intranasally infected C57BL/6 mice with ΔflaA L. pneumophila 
expressing BlaM-RalF, as WT L. pneumophila do not establish a productive infection in 
mice that encode a functional NAIP5 allele as CFUs do not increase and are cleared 
from C567BL/6 mice (Figure 3-4D) (Molofsky et al., 2006; Ren et al., 2006). In this 
model, similar to WT L. pneumophila infection of A/J mice expressing a hypomorphic 
NAIP5 allele, the lungs of C57BL/6 mice exhibit approximately a one-log increase in 
ΔflaA L. pneumophila CFUs by 24-48 hours post-infection (Figure 3-4C & D) (Case et 
al., 2009). The mice are subsequently able to control infection, with minimal bacterial 
CFUs detected in the lungs by 5 days post-infection (Figure 3-4C & D) (Molofsky et al., 
2006). Expression of the plasmid containing BlaM-RalF did not affect the replication of 
ΔflaA L. pneumophila in vivo (Figure 3-4C). After intranasal inoculation with L. 
pneumophila, we performed bronchoalveolar lavage to isolate cells from the airway 
space at various time points and loaded them with CCF4-AM to detect T4SS-mediated 
injection of BlaM-RalF. At four hours post-inoculation, we detected T4SS-mediated 
translocation of β-lactamase activity in nearly 50% of cells recovered from the airway of 
mice infected with ΔflaA L. pneumophila (Figure 3-7A). Greater than 95% of the T4SS-
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injected cells were alveolar macrophages, as indicated by their expression of CD11c and 
Siglec F (Stevens et al., 2007; Sung et al., 2006). Similar results were obtained with WT 
L. pneumophila at this time point (data not shown). Consistent with our in vitro data, we 
did not observe injection of BlaM-RalF in mice infected with the ΔdotA strain, which is 
unable to translocate effectors into host cells and cannot establish a productive infection 
in vivo.  
 
At later times post-infection, we detected recruitment of a large population of neutrophils 
to the airway space of ΔflaA L. pneumophila-infected mice that did not occur in mice 
infected with ΔdotA L. pneumophila (Figures 3-8A & B), consistent with previous studies 
indicating that neutrophil recruitment is T4SS-dependent (Barry et al., 2013; Casson et 
al., 2013; Frutuoso et al., 2010; LeibundGut-Landmann et al., 2011). When we identified 
cells injected by L. pneumophila in the airway space at 24 hours post-infection, we again 
identified alveolar macrophages as being positive for T4SS-mediated injection, but we 
could also identify injected cells that expressed high levels of Ly6G and were negative 
for MHC class II (Figure 3-7B). We determined these injected Ly6G+ cells to be 
neutrophils, as they expressed low levels of Ly6C, a cell surface marker highly 
expressed on inflammatory monocytes (Figure 3-3C) (Fleming et al., 1993; Sunderkötter 
et al., 2004). The frequency of injected neutrophils was much lower than that of injected 
alveolar macrophages (Figure 3-7C). However, due to the large influx of neutrophils, the 
total number of injected neutrophils was comparable to or greater than the total number 
of injected alveolar macrophages at 24, 48, and 72 hours post-infection (Figure 3-7D). 
 
As we could detect robust T4SS-mediated injection of BlaM-RalF into cells of the airway 
space, we wanted to determine whether cells within the lung interstitium were injected by 
L. pneumophila as well. Notably, we again observed T4SS-mediated injection into 
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alveolar macrophages and neutrophils within lung homogenates (Figure 3-9A). As in the 
airway space, we detected a large influx of neutrophils into the lung tissue of ΔflaA-
infected mice, but not in mice infected with the ΔdotA strain of L. pneumophila (Figures 
3-8C & D). Though in vitro we observed T4SS-mediated injection into bone marrow-
derived dendritic cells as well as A549 alveolar epithelial cells (Figure 3-5B & C), we did 
not detect injection into lung dendritic cells or CD326+ airway epithelial cells, suggesting 
that L. pneumophila does not efficiently infect or translocate effectors into these cell 
types during a permissive mouse model of infection (Figure 3-9A). We also did not 
observe injection into inflammatory monocytes, plasmacytoid dendritic cells, eosinophils, 
B cells, T cells, NK cells, or endothelial cells within the lung tissue at any time assayed 
post infection (Figure 3-3C & D). The frequency of T4SS-injected neutrophils in the lung 
tissue was much lower than that seen in alveolar macrophages, similar to what we 
observed in the airway space (Figure 3-9B). At four hours post-infection, the majority of 
cells receiving T4SS-translocated effectors in the lung tissue were alveolar 
macrophages, but at later times, many of the T4SS-injected cells were neutrophils 
(Figure 3-9C). Importantly, L. pneumophila recovered at 48 and 72 hours post-infection 
retained the reporter plasmid, indicating that the plasmid is stably maintained during in 
vivo infection even in the absence of antibiotic selection (Figure 3-4B). A previous study 
examining a non-permissive model of C57BL/6 mice infected with WT L. pneumophila 
also found that CD45-negative cells or lung epithelial cells did not appear to have taken 
up L. pneumophila, with alveolar macrophages appearing to be the primary cells infected 
at early time points post-infection, followed by infection of recruited neutrophils at one 
day post-infection (LeibundGut-Landmann et al., 2011), suggesting that in both 
permissive and non-permissive mouse models, similar lung cell types are infected. 
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Neutrophils and alveolar macrophages in the lungs of infected mice harbor viable 
Legionella pneumophila bacteria and produce cytokines 
Alveolar macrophages are thought to be the primary cell type that is infected by L. 
pneumophila and supports bacterial replication (Nash et al., 1984). A previous study 
using a non-permissive model of C57BL/6 mice infected with WT L. pneumophila also 
found that that recruited neutrophils take up L. pneumophila in the lung, but whether L. 
pneumophila could translocate effectors into neutrophils or survive within these cells was 
not examined (LeibundGut-Landmann et al., 2011). As we observed that both alveolar 
macrophages and neutrophils in L. pneumophila–infected lungs were injected by the 
T4SS, we sought to determine whether in addition to alveolar macrophages, neutrophils 
also contained viable bacteria. We therefore sorted total alveolar macrophages and 
neutrophils from the lungs of mice infected intranasally with L. pneumophila and 
enumerated bacteria from lysed cells. As a comparison, we also sorted total 
inflammatory monocytes, a population of cells negative for T4SS injection, from these 
infected mice as well. As expected, alveolar macrophages isolated twenty-four hours 
after infection contained viable bacteria (Figure 3-10A). In contrast, inflammatory 
monocytes contained very few viable L. pneumophila, consistent with the lack of 
observed T4SS-dependent translocation into these cells (Figure 3-10A). Interestingly, 
neutrophils from ΔflaA-infected mice contained viable bacteria at a frequency consistent 
with the extent of injection, suggesting that injected neutrophils harbor viable bacteria in 
the airway and lung tissue. Although the absolute frequency of viable L. pneumophila in 
alveolar macrophages was greater than within neutrophils (nearly 10 bacteria per 100 
alveolar macrophages vs. 1 bacterium per 100 neutrophils), the higher absolute 
numbers of neutrophils present during infection results in the unexpected finding that 
neutrophils actually contain nearly twice as many viable bacteria as alveolar 
macrophages (Figure 3-10B). To examine whether this was also the case at the peak of 
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pulmonary bacterial load, we sorted alveolar macrophages and neutrophils from mice 48 
hours PI (Figure 5C &D). As with 24 hours PI, although a higher frequency of alveolar 
macrophages contained viable L. pneumophila, in total there were more L. pneumophila 
in neutrophils than alveolar macrophages. 
 
The presence of neutrophils in the airway space during infection correlates with lower 
bacterial burden, thought to be in part due to their potent bactericidal activity (Barry et 
al., 2013; Casson et al., 2013; LeibundGut-Landmann et al., 2011). However, as our 
data suggest that L. pneumophila inject and survive within neutrophils, thus potentially 
activating cytosolic immunosurveillance pathways within these cells, we next examined 
whether or not infected neutrophils may also contribute to the T4SS-dependent 
production of pro-inflammatory cytokines important for bacterial clearance. To test this, 
following intranasal infection with either ΔdotA or ΔflaA L. pneumophila, we measured 
cytokines secreted by alveolar macrophages isolated at four hours post-infection or 
neutrophils isolated at twenty-four hours post-infection. Alveolar macrophages from 
ΔflaA-infected mice secreted TNF and IL-1α, whereas macrophages from ΔdotA–
infected mice did not. Interestingly, neutrophils from mice infected with ΔflaA L. 
pneumophila also secreted substantial amounts of TNF and IL-1α, whereas neutrophils 
from mice infected with ΔdotA L. pneumophila did not secrete detectable levels of IL-1α 
and secreted significantly less TNF, which correlates with the lack of detectable cytokine 
production observed during pulmonary infection with ΔdotA L. pneumophila (Fig 3-10E & 
F). Intriguingly, these data demonstrate that in addition to alveolar macrophages, 
neutrophils also produce proinflammatory cytokines in the context of T4SS-competent L. 
pneumophila infection. This indicates that in addition to their potent bactericidal activity, 
neutrophils may contribute to the control of infection by other immune effector 
mechanisms such as cytokine production. 
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Conclusion 
Here, I describe the creation of a sensitive and faithful fluorescent reporter to track the 
activity of the T4SS of L. pneumophila within in host cells. Using this system, I am able 
to detect injection by the T4SS into cells both in vitro and in vivo. In vitro, injected harbor 
viable L. pneumophila, demonstrating that this fluorescent detection system correlates 
with active infection in host cells. Cells not injected by the T4SS do not contain viable L. 
pneumophila. Injection is detectable in macrophages, dendritic cells, and alveolar 
epithelial cells in vitro. These data indicate that injection can occur into a variety of cell 
types. In a pulmonary model of L. pneumophila infection in vivo, however, injection is 
only detected in alveolar macrophages and neutrophils at multiple times PI. Importantly, 
viable CFUs are obtained from these cell types, indicating that L. pneumophila are able 
to survive and potentially replicate within these cells. Beyond alveolar macrophages and 
neutrophils being a niche for L. pneumophila in vivo, the cells also secrete IL-1α and 
TNF in response to infection with virulent, but not avirulent infection. These data indicate 
a dual role for phagocytic cells during pulmonary L. pneumophila infection as both 
intracellular niche and important activators of subsequent immune responses. 
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Figure 3-1. β-lactamase translocation into cells requires fusion to RalF and a functional 
type IV secretion system. (A) Schematic of the BlaM-RalF expression plasmid. β-
lactamase (BlaM) is tagged with the M45 peptide and fused to the N-terminus of the 
effector protein RalF. The icmR promoter drives the expression of this fusion protein. (B) 
Lysates from WT, ΔdotA, and ΔflaA L. pneumophila expressing either β-lactamase 
(BlaM) alone or Blam-RalF fusion reporter plasmids were blotted with an α-M45 antibody 
to detect reporter protein expression. (C) Bone marrow-derived macrophages (BMDMs) 
were treated with PBS (Unfx) or infected with WT, ΔdotA, and ΔflaA strains of Legionella 
pneumophila (Lp) expressing BlaM or BlaM-RalF for 8 hours with an MOI=5.  Cells were 
then loaded with CCF4-AM and analyzed by flow cytometry. Cells positive for cleaved 
CCF4-AM (blue) fluorescence are gated and the frequency of injected cells for each 
condition is denoted within the gate. Bar graph shows mean ± standard error of the 
mean (SEM) of triplicate wells. Representative of three independent experiments. 
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Figure 3-2. Viable Legionella pneumophila are predominantly associated with 
macrophages positive for T4SS-dependent translocation. (A) BMDMs were left 
untreated (Unfx) or infected with WT, ΔdotA, or ΔflaA Lp for 8 hours with an MOI=5. 
Cells were then loaded with CCF4-AM, fixed, permeabilized, and stained with a 
polyclonal antibody against Lp. Cells were analyzed by flow cytometry. The percentages 
of cells positive for Lp as determined by staining and cells positive for T4SS injection are 
denoted within the gates. (B & C) Cells were treated similarly to (A), but infected with an 
MOI=10 for 4 hours and analyzed using an Amnis ImageStream imaging flow cytometer. 
(D) BMDMs were left untreated, treated with LPS, or infected with ΔdotA or ΔflaA Lp for 
8 hours with an MOI=5 in the presence of exogenous thymidine (100µg/mL) and loaded 
with CCF4-AM. Samples infected with ΔdotA were sorted in bulk for loaded cells. Cells 
infected with ΔflaA were then sorted based on uncleaved or cleaved CCF4-AM signal, 
lysed, and plated on CYE plates. CFUs were then enumerated. Bar graphs show mean 
only or mean ± SEM of triplicate samples. Representative of 2 independent experiments. 
ns=not significant. 
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Figure 3-3. Gating strategies for fluorescence-based imaging flow cytometry and 
conventional flow cytometry. (A & B) BMDMs were left untreated or infected with ΔdotA 
or ΔflaA Lp for 8 hours with an MOI=10. Cells were then loaded with CCF4-AM, fixed, 
permeabilized, and stained with an antibody against Lp. Cells were then analyzed using 
the Amnis ImageStream imaging flow cytometer. Focused singlets that took up CCF4-
AM were selected as shown in (A) and the frequency of injected (cleaved) cells was 
deteremined by gating as well as the amount of staining for Lp in either uninjected 
(uncleaved) or injected cells. The frequency of injection and Lp+ cells was then 
determined as shown in (B). (C & D) Murine lung was homogenized and single cell 
suspensions were stained with extracellular markers to identify various populations of 
immune cells including alveolar macrophages (AMΦ) (CD45+, Ly6G-, Ly6C-, CD11c+, 
Siglec F+), neutrophils (NΦ) (CD45+, Ly6G+, Ly6Clow), inflammatory monocytes (iMC) 
(CD45+, Ly6G-, Ly6Chi), conventional DCs (cDC) (CD45+, Ly6G-, Ly6C-, CD11c+, Siglec 
F-, MHCII+) T cells (CD45+, CD3ε+, CD19-), B cells (CD45+, CD3ε-, CD19+) and NK cells 
(CD45+, CD3ε-, CD19-, NK1.1+). Airway epithelial cells (AEC) (CD45-, CD31+, CD326+) 
and lung endothelial cells (LEC) (CD45-, CD31+, CD326-) were also identified. Gates 
shown are representative of the gates used throughout this study. 
  
56	  
 
 
Figure 3-4. The BlaM-RalF expression plasmid is stably maintained during both in vitro 
and in vivo infection. (A) BMDMs were infected with ΔdotA or ΔflaA Lp for 8 hours with 
an MOI=5. Cells were then sorted based on cleaved CCF4-AM signal, lysed, and plated 
on CYE agar plates containing either streptomycin or chloramphenicol. CFUs were then 
enumerated. Bar graph shows mean ± SEM. N=3. (B) Mice were infected intransally with 
ΔdotA or ΔflaA Lp for 48 or 72 hours. The lungs of the infected mice were then 
homogenized and the cells were lysed and plated on CYE plates as in (A). Points 
represent individual mice with the mean denoted as a line. N=3-4 mice per group. (C) 
Mice were infected with infected intranasally with 1x106 JR32 ΔflaA, 5x106 JR32 ΔflaA, 
or 5x106 JR32 ΔflaA expressing the BlaM-RalF plasmid. CFUs were enumerated on 
CYE plates containing streptomycin. N=3 mice per group. (D) Mice were infected with 
5x106 CFUs of BlaM-RalF-expressing strains of JR32 WT, ΔdotA, or ΔflaA L. 
pneumophila and bacterial burdens were enumerated. N= 2-4 mice per group. 
  
57	  
 
 
Figure 3-5. Legionella pneumophila T4SS-dependent translocation is detected in 
dendritic cells and alveolar epithelial cells during in vitro infection. BMDMs (A), bone 
marrow-derived dendritic cells (BMDCs) (B), and A549 cells (C) were left untreated or 
infected with WT, ΔdotA, or ΔflaA Lp for 4, 8, or 12 hours with an MOI=5. Cells were 
then loaded with CCF4-AM and analyzed for injection by flow cytometry. Representative 
plots show injection 8 hours post infection. Graphs show mean ± SEM of triplicate wells. 
Representative of 2 independent experiments, N=3. 
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Figure 3-6. Bacterial motility increases the frequency of T4SS-injected macrophages, but 
not T4SS-injected alveolar epithelial cells. A549 cells (A) and BMDMs (B) were left 
untreated, treated with LPS, or infected with WT, ΔdotA, or ΔflaA Lp at MOI=5 for 4 
hours that were either non-motile or grown under conditions that induce motility. Cells 
were then loaded with CCF4-AM and analyzed for injection by flow cytometry. Bar 
graphs are mean ± SEM. Representative of 2 independent experiments, N=3. 
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Figure 3-7. Alveolar macrophages and neutrophils in the airway space are injected by 
the Legionella pneumophila T4SS. C57BL/6J mice were infected intranasally with PBS 
vehicle control, ΔdotA Lp, or ΔflaA Lp. At 4 (A) or 24 (B) hours post infection, cells in the 
airway space were isolated, enumerated, loaded with CCF4-AM, and stained for cell 
surface markers. Cells were then analyzed for injection by flow cytometry and cell 
surface marker expression. Representative of 2 independent experiments, N=4 mice per 
group.  (C & D) Alveolar macrophages (MΦ) and neutrophils from the airway space of 
mice infected with ΔflaA Lp were isolated at 4, 24, 48, or 72 hours post infection and 
loaded with CCF4-AM. The percentage (C) and total number (D) of cells injected by Lp 
in each population was quantified. Graphs show mean ± SEM. N=3-4 mice per group.  
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Figure 3-8. Infection with ΔflaA Legionella pneumophila recruits immune cells to the 
lungs of infected mice. Mice were infected intranasally with ΔflaA (A & C) or ΔdotA (B & 
D) Lp. At various times post infection, airway space cells (A & B) and lung cells (C & D) 
were separately isolated, enumerated, and stained for extracellular markers. The 
frequency and number of alveolar macrophages, neutrophils, monocytes, conventional 
DCs, T cells, B cells, and NK cells was calculated. Graphs show mean ± SEM. N=3-4 
mice per group. 
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Figure 3-9. The Legionella pneumophila T4SS injects alveolar macrophages and 
neutrophils in the lung. (A) Mice were infected intranasally with ΔdotA or ΔflaA L. 
pneumophila for 24 hours. Lung cells were then isolated, loaded with CCF4-AM, and 
stained. Flow plots are pre-gated on the denoted cell populations. Representative of 3 
independent experiments, N=4 mice per group. (B & C) Mice were infected with ΔflaA Lp 
and lung cells were isolated at various times post infection. The percentage (B) and total 
number (C) of cells injected by Lp in each population was quantified. Graphs show mean 
± SEM. N=3-4 mice per group. cDC=conventional dendritic cell. 
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Figure 3-10. Alveolar macrophages and neutrophils from infected mice contain viable 
Legionella pneumophila and secrete cytokines. (A+C) Mice were intransally infected with 
ΔdotA or ΔflaA Lp. At 24 (A) or 48 (B) hours post-infection, the lungs and airway space 
were homogenized and single cell suspensions were stained for cell surface markers to 
identify alveolar macrophages, neutrophils and inflammatory monocytes. These cell 
populations were sorted using a flow cytometer, lysed, and plated on CYE agar to 
ennumerate L. pneumophila CFUs. (B) The frequency of viable bacteria per cell type in 
(A) was then multiplied by the frequency of the appropriate cell type found in a total of 
106 lung cells. (D) Similarly, the frequency of viable bacteria per cell type in (C) was 
multiplied by the frequency of the appropriate cell type found in a total of 106 lung cells. 
(E) Alveolar macrophages were isolated by bronchoalveolar lavage 4 hours after 
intranasal infection with ΔdotA or ΔflaA Lp and cultured overnight. Supernatants were 
collected and TNF and IL-1α concentrations were determined by ELISA. (F) Neutrophils 
were isolated and sorted at 24 hours PI from mice treated as in (A) and then cultured 
overnight as in (C). Graphs show mean ± SEM. *p<0.05, ***p<0.0005 
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CHAPTER 4 
IL-1 INDUCES INNATE BYSTANDER CYTOKINE PRODUCTION TO BYPASS 
BACTERIAL BLOCKADE OF HOST PROTEIN SYNTHESIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been submitted and reviewed as an article entitled “IL-1 induces innate 
bystander cytokine production to bypass bacterial blockade of host protein synthesis” by 
Alan M. Copenhaver, Cierra N. Casson, Hieu T. Nguyen, Matthew M. Duda, and Sunny 
Shin. Proceedings of the National Academy of Sciences, 2015. 
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Abstract 
The innate immune system is critical for host defense against microbial pathogens, yet 
many pathogens utilize virulence factors to impair immune cell function. Here, we 
employed the intracellular bacterium Legionella pneumophila to understand how the 
immune system overcomes pathogenic activities. L. pneumophila utilizes a type IV 
secretion system (T4SS) to translocate bacterial effectors that potently block host 
translation in infected host cells. Despite this translational block, virulent L. pneumophila 
elicits a robust inflammatory response, but the basis for this is poorly understood. Single 
cell analysis of cytokine production by infected and uninfected cells revealed that 
infected macrophages produce IL-1α and IL-1β but poorly synthesize the cytokines IL-6, 
TNF, and IL-12, which are critical for controlling L. pneumophila infection. Intriguingly, 
uninfected bystander immune cells produced IL-6, TNF, and IL-12, and IL-1 receptor (IL-
1R) signaling was required for this cytokine production. Thus, our data demonstrate 
functional heterogeneity in production of critical protective cytokines in the response to 
bacterial infection. These data suggest collaboration between infected and uninfected 
cells that enables the immune system to bypass protein synthesis inhibition and 
generate a robust immune response against L. pneumophila.  
 
Significance Statement 
Pathogens use virulence factors to inhibit key immune cell functions and would be 
expected to impair immune responses to infection. However, immune responses are still 
activated during infection, suggesting that the immune system has evolved mechanisms 
for overcoming pathogenic activity. Here, we demonstrate that cells infected with L. 
pneumophila produce IL-1 despite a pathogen-imposed host translational block, but are 
unable to robustly produce other critical cytokines. IL-1R signaling allowed uninfected 
bystander cells to produce protective cytokines. Our data thus demonstrate a key role for 
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communication between infected and uninfected bystander cells in overcoming 
pathogenic activities. This mechanism of immune activation has broad significance for 
our understanding of how successful immune responses are generated against 
pathogens. 
 
Introduction 
Initiation of innate immune responses to microbial pathogens is thought to involve the 
direct recognition of pathogen-associated molecular patterns (PAMPs) by membrane-
bound and cytosolic pattern recognition receptors (PRRs) on infected cells (Janeway 
and Medzhitov, 2002; Vance et al., 2009). However, many pathogens utilize virulence 
factors that interfere with essential immune signaling processes, including NF-κB and 
MAPK signaling and host protein synthesis (Krachler et al., 2011; Roy and Mocarski, 
2007; Viboud and Bliska, 2005). Such virulence factors limit cell-intrinsic immune 
activation of infected cells. The mechanisms that enable the host to circumvent 
pathogen manipulation of host cell signaling processes remain poorly understood. 
 
The Gram-negative bacterium Legionella pneumophila encodes a specialized Dot/Icm 
type IV secretion system (T4SS) that injects bacterial effector proteins into host cells to 
facilitate bacterial intracellular survival and replication (Berger and Isberg, 1993; Hubber 
and Roy, 2010; Marra et al., 1992). A subset of effector proteins, Lgt1, Lgt2, Lgt3, SidI, 
SidL, Pkn5, and Lpg1489, block host protein synthesis, in part by targeting translational 
elongation factors (Barry et al., 2013; Belyi et al., 2006; 2008; Shen et al., 2009). 
Furthermore, translational initiation is inhibited during infection due to diminished mTOR 
signaling (Ivanov and Roy, 2013). These activities result in a greater than 90% block in 
host translation in infected host cells (Fontana et al., 2011; McCusker et al., 1991). 
Nevertheless, infection by L. pneumophila leads to the robust production of pro-
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inflammatory cytokines, such as TNF, IL-6, IL-1α, IL-1β, and IL-12 (Barry et al., 2013; 
Casson et al., 2013; LeibundGut-Landmann et al., 2011; Shin et al., 2008; Spörri et al., 
2006). Moreover, the presence of the T4SS paradoxically enhances levels of cytokine 
production in response to L. pneumophila, suggesting that much of the cytokine 
response against L. pneumophila is mediated by cytosolic immune sensing of bacterial 
ligands and virulence activities (Fontana et al., 2011; 2012; Krachler et al., 2011; Roy et 
al., 1998; Shin et al., 2008; Spörri et al., 2008). 
 
It is unclear, then, how the host is able to mount a pro-inflammatory cytokine response 
when L. pneumophila infection potently blocks host protein synthesis. At the population 
level, decreased host protein synthesis leads to preferential translation of the most 
abundant cytokine transcripts (Ivanov and Roy, 2013). At the single cell level, directly 
infected cells overcome the translational block and selectively synthesize IL-1α and IL-
1β through a mechanism involving MyD88-dependent transcriptional expression of IL-1α 
and IL-1β (Asrat et al., 2014). However, whether mechanisms that enable selective 
translation of IL-1 also apply more broadly to other key cytokines and immune effector 
proteins is unclear. Alternatively, as uninfected bystander cells are present both in vitro 
and in vivo during infection, we considered the possibility that these bystander cells 
might somehow respond to infection and produce cytokines instead (Copenhaver et al., 
2014). Here, by tracking immune responses in L. pneumophila-infected cells at the 
single cell level, we demonstrate that although infected cells that have received T4SS 
effectors are able to synthesize IL-1α and IL-1β, they are poor producers of other key 
cytokines. Instead, bystander cells that have not received T4SS effectors are the primary 
producers of TNF, IL-6, IL-12, and the costimulatory molecule CD86 during both in vitro 
and in vivo infection. Importantly, loss of IL-1R signaling leads to reduced bystander 
cytokine production and increased bacterial burden in vivo, suggesting that the IL-1 
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released from infected cells mediates production of pro-inflammatory cytokines by 
bystander cells. Overall, our data suggest that release of IL-1 by infected cells signals 
the presence of virulent infection, enabling the host to generate a robust innate immune 
response despite a pathogen-imposed translational block. 
 
Results 
 
Cells that have not received bacterial effectors are the primary producers of pro-
inflammatory cytokines during in vitro infection 
Infection with virulent L. pneumophila expressing a type IV secretion system (T4SS) 
leads to an enhanced cytokine response despite bacterial inhibition of host translation. 
How this enhanced T4SS-dependent cytokine response is generated remains unclear. 
We considered the possibility that directly infected macrophages possess cell-intrinsic 
mechanisms for overcoming the translational block to selectively synthesize cytokines. 
Alternatively, cytokines may be produced by bystander cells that are uninfected or have 
taken up bacteria that failed to translocate effector proteins (Copenhaver et al., 2014). 
To determine whether T4SS-injected cells or uninfected bystander cells produce 
cytokines during infection, we utilized a fluorescence-based system that detects a 
translocated L. pneumophila effector protein (RalF) fused to β-lactamase (BlaM) 
(Copenhaver et al., 2014; Knapp et al., 2003). In the absence of BlaM activity, 409nm 
excitation of the cell-permeable BlaM fluorescent substrate CCF4-AM results emission of 
green fluorescence at 518 nm. However, T4SS-translocated BlaM-RalF results in 
cleavage of CCF4-AM and a shift in emission to blue fluorescence at 447 nm. This 
system enables robust discrimination of productively infected and uninfected cells within 
tissues in vivo or in cultured cells in vitro (Copenhaver et al., 2014). 
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We infected bone marrow-derived macrophages with L. pneumophila encoding the 
BlaM-RalF reporter. As flagellin delivered by the T4SS into the host cell cytosol induces 
rapid cell death via NAIP5 detection and inflammasome activation, we infected 
macrophages with the virulent ΔflaA strain lacking flagellin (Molofsky et al., 2006; Ren et 
al., 2006; Zamboni et al., 2006). Following infection, macrophages were loaded with 
CCF4-AM and intracellularly stained for various cytokines at multiple time points post-
infection. (Figure 4-1 & 4-2). Macrophages infected with avirulent L. pneumophila lacking 
the Dot/Icm T4SS (ΔdotA) demonstrated no BlaM-RalF activity as expected. In the 
virulent ΔflaA infection, we found that TNF is rapidly produced in response to infection, 
but that T4SS-injected cells were poor producers of TNF at all time points assayed 
(Figure 4-1A). Instead, the majority of cells robustly producing TNF were cells that had 
not received T4SS effectors. Likewise, T4SS-injected cells poorly produced IL-6. 
Instead, IL-6 was primarily produced by uninjected cells (Figure 4-1B). Similar findings 
were obtained for IL-12 and CD86 (Figure 4-2). In contrast, IL-1α and IL-1β were 
robustly produced by both T4SS-injected cells and uninjected cells (Figure 4-1C &D), 
indicating that T4SS-injected cells produce IL-1α and IL-1β despite the translational 
block imposed by L. pneumophila effector proteins, consistent with recent findings (Asrat 
et al., 2014).  
 
To determine whether the decreased cytokine production in T4SS-injected cells is due to 
decreased translation or transcription, we performed qRT-PCR on sorted T4SS-injected 
and uninjected cells (Figure 4-1E). Both injected and uninjected cells displayed marked 
increases in transcript levels for the cytokines IL-1α, IL-1β, TNF, and IL-6 relative to 
uninfected cells, with injected cells consistently exhibiting a greater increase in cytokine 
transcript levels, consistent with recent findings (Asrat et al., 2014). Thus, the decreased 
production of immune proteins by injected cells is not due to a lack of transcriptional 
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activation and most likely is a direct consequence of the translational block. Taken 
together, these data suggest that although productively infected cells can bypass the 
translational block to produce IL-1α and IL-1β, they poorly translate TNF, IL-6, IL-12, and 
CD86. Instead, bystander cells preferentially produce these proteins. 
 
There are currently seven identified effectors in virulent L. pneumophila that inhibit 
protein translation in host cells (Barry et al., 2013; Belyi et al., 2013). To determine if 
these effectors prevent cytokine production in injected cells, we infected BMDMs with 
strains of L. pneumophila that lack either five of the known effectors (Lgt1, Lgt2, Lgt3, 
SidI, SidL)(Δ5) or all seven (Δ5 and Pkn5 and Lpg1489) (Δ7ΔflaA) of the known 
effectors. At four hours PI, cells injected by the Δ5 or Δ7ΔflaA strains produced more 
TNF than cells injected by their parental WT counterparts (Figure 4-3A &D). This 
increase occurred both in the frequency of TNF-producing injected cells as well as the 
gMFI of injected cells producing TNF. At 16 hours PI, however, there was no difference 
in the frequency of TNF-producing injected cells in either the Δ5 or Δ7ΔflaA strains and 
gMFI was only different in the Δ7ΔflaA strain compared to the parent strain (Figure 4-3B 
&E). IL-6 production by injected cells was also unaffected by the presence or absence of 
these effectors (Figure 4-3C &F). These data indicate that T4SS effectors that block 
protein translation effect early, but not later cytokine production in infected cells. 
 
Bystander alveolar macrophages and neutrophils are predominant producers of 
TNF during L. pneumophila infection  
Our in vitro findings indicate that many key protective cytokines are primarily generated 
by bystander macrophages during infection by pathogens that interfere with cell intrinsic 
immune defense. In vivo, multiple cell populations exist, and distinct immune populations 
may possess alternative mechanisms for overcoming pathogen-induced translational 
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blockade. We therefore intranasally infected WT mice with L. pneumophila strains 
expressing BlaM-RalF and examined TNF production in airway-resident alveolar 
macrophages and recruited neutrophils, as they are the primary cell types that receive L. 
pneumophila T4SS effectors (Copenhaver et al., 2014). Following infection with ΔflaA L. 
pneumophila, we observed a significant increase in both the percentage and total 
numbers of TNF-producing airway alveolar macrophages and neutrophils (Figure 4-4), 
consistent with previous findings showing that cytosolic immune sensing of T4SS activity 
is required for maximal TNF production (Shin et al., 2008; Spörri et al., 2006). We 
observed that T4SS-injected alveolar macrophages and neutrophils did not produce 
TNF. Instead, TNF was produced almost exclusively by uninjected alveolar 
macrophages and neutrophils (Figure 4-4). These data, along with our data in 
macrophages in vitro, indicate that infected cells are poor producers of proinflammatory 
cytokines and that uninfected cells are the major TNF-producers. 
 
In contrast, both injected and uninjected alveolar macrophages produced IL-1α and IL-
1β, in agreement with our in vitro findings (Figure 4-5). PBS vehicle control and avirulent 
ΔdotA infection yielded no significant increase in TNF-positive alveolar macrophages or 
neutrophils (Figure 4-4), corroborating with previous findings that TNF is undetectable in 
the bronchoalveolar lavage fluid or serum isolated from similarly treated mice (Shin et 
al., 2008; Spörri et al., 2006). Consistent results were also obtained from alveolar 
macrophages and neutrophils isolated from lung tissue (Figure 4-6). These data indicate 
that although cytosolic immune sensing of T4SS-translocated bacterial products is 
critical to elicit TNF production, TNF is produced by uninjected bystander alveolar 
macrophages and neutrophils that have not received T4SS effectors. 
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Bystander inflammatory monocytes and dendritic cells produce TNF and CD86 
during L. pneumophila infection 
Inflammatory monocytes and conventional dendritic cells are also recruited to the lung 
during L. pneumophila infection. In contrast to alveolar macrophages and neutrophils, 
these cell populations are not productively infected by L. pneumophila and do not 
receive T4SS effectors (Copenhaver et al., 2014; LeibundGut-Landmann et al., 2011). 
Even so, inflammatory monocytes and dendritic cells produced significant amounts of 
TNF and were the primary cell types in the lung responsible for producing TNF during 
ΔflaA L. pneumophila infection (Figures 4-7A & B). In contrast, inflammatory monocytes 
and dendritic cells from ΔdotA-infected mice did not exhibit an increase in TNF 
production compared to cells from PBS-infected mice. Inflammatory monocytes and 
dendritic cells also substantially increased expression of CD86 during infection with 
virulent ΔflaA L. pneumophila compared to PBS or ΔdotA infection, and were the primary 
cell types expressing CD86 (Figure 4-7C & D). Alveolar macrophages and neutrophils 
did not increase expression of CD86 during ΔflaA infection (Figure 4-8). These data 
indicate that although inflammatory monocytes and dendritic cells are not productively 
infected and do not receive T4SS-translocated products, they are the primary cell types 
that express TNF and CD86 during virulent L. pneumophila infection as measure by 
intracellular cytokine staining. 
 
IL-1 signaling is critical for activating bystander immune cells to produce 
cytokines and express CD86 
Maximal immune responses to L. pneumophila require cytosolic sensing of T4SS activity 
(Shin et al., 2008), yet our data indicate that the majority of cytokine- and CD86-
producing cells are bystander innate immune cells that have not received T4SS 
effectors. Given that T4SS-injected cells are capable of producing IL-1α and IL-1β, we 
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considered the possibility that IL-1α and IL-1β released by infected cells might play a 
role in instructing bystander cells to produce other key inflammatory cytokines. Notably, 
IL-1α and IL-1β can elicit expression of other cytokines (Dinarello, 1996; Kohase et al., 
1987), and IL-1R signaling is critical for innate immune control of L. pneumophila 
infection (Barry et al., 2013; Casson et al., 2013; LeibundGut-Landmann et al., 2011; 
Mascarenhas et al., 2015). The crucial role of IL-1 in early host defense has been 
primarily attributed to IL-1-dependent expression of neutrophil-attracting chemokines by 
epithelial cells and subsequent neutrophil recruitment to the site of infection (Barry et al., 
2013; Casson et al., 2013; LeibundGut-Landmann et al., 2011; Mascarenhas et al., 
2015). We hypothesized that IL-1R signaling would also be critical for instructing 
bystander innate immune cells to produce cytokines. We therefore intranasally infected 
WT or Il1r1-/- (IL-1R-/-) mice with ΔflaA L. pneumophila and assayed TNF production 24 
hours later. Critically, IL-1R-/- mice exhibited significant reductions in both the 
percentages and total numbers of TNF-producing alveolar macrophages, neutrophils, 
dendritic cells and inflammatory monocytes compared to WT mice, in which large 
numbers of the aforementioned cells produced TNF (Figure 4-9 & 4-10). Although a 
percentage of IL-1R-/- dendritic cells and inflammatory monocytes remained positive for 
TNF, it was only minimally higher than the basal percentage of TNF-positive cells 
observed in WT or IL-1R-/- mice infected with avirulent ΔdotA L. pneumophila (Figure 4-
11). Consistent with the decreased numbers of TNF-producing cells in IL-1R-/- mice, TNF 
levels in the bronchoalveolar lavage of IL-1R-/- mice were significantly reduced compared 
to WT mice (Figure 4-11E). IL-12p40 levels in IL-1R-/- mice were also significantly 
reduced (Figure 4-9E). Furthermore, IL-1R-/- mice also exhibited a significant decrease in 
the percentages and total numbers of CD86-expressing inflammatory monocytes and 
dendritic cells compared to WT controls (Figure 4-10). In contrast, IL-6 levels were 
unaffected, indicating that IL-1 signaling is not required for production of all responses by 
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bystander cells during L. pneumophila infection (Figure 4-9E). Finally, injection of 
neutralizing antibodies against IL-1α and IL-1β resulted in a significant decrease in the 
levels of TNF and IL-12p40, but not IL-6, with neutralization of IL-1α and IL-1β together 
having the greatest effect (Figure 4-12). Overall, these data indicate a crucial role for IL-
1 signaling in directing the optimal production of the pro-inflammatory cytokines TNF and 
IL-12p40 as well as the costimulatory molecule CD86 by bystander innate immune cells 
during pulmonary L. pneumophila infection. 
 
BMDMs are reported to not express the IL-1R and should therefore not respond to IL-1 
stimulation in vitro (Demuth et al., 1996). To see, however, whether IL-1R signaling 
occurs during L. pneumophila infection in vitro, we infected with WT or IL-1R-/- BMDMs 
with L. pneumophila and assayed for cytokine production by flow as well as be ELISA 
(Figure 4-13A &B). An equal frequency of IL-1R-/- bystander BMDMs produced TNF in 
response to L. pneumophila as compared to WT cells (Figure 4-13A) and IL-6 production 
in response to infection was also equivalent between the two genotypes of BMDMs 
(Figure 4-13B).Indeed, treating BMDMs with varying concentrations of recombinant IL-
1α, IL-1β, or both combined did not elicit TNF or IL-6 production from these cells (Figure 
4-13C). Treatment of NIH/3T3 cells, an epithelial cell line known to express the IL-1R, 
elicited IL-6 production, demonstrating that the recombinant IL-1 is competent to induce 
signaling (Figure 4-13D). These data, along with the decreased, but present cytokine 
response to L. pneumophila infection from IL-1R-/- mice in vivo, suggest that additional 
signals may drive bystander cytokine responses during infection. 
 
To determine if IL-1 signaling is sufficient to drive TNF production on other innate cell 
types, we treated alveolar macrophages, bone marrow-derived dendritic cells (BMDCs) 
or inflammatory monocytes isolated from mouse bone marrow and treated with IL-1α, IL-
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1β, or both in combination. A small, but consistent frequency of BMDCs stained for TNF 
production in response to IL-1 treatment (Figure 4-14A). These BMDCs also increased 
expression of CD86 in response to IL-1 treatment (Figures 4-14B). BMDCs also 
produced a low level of TNF and IL-6 in response to IL-1 treatment as measured by 
ELISA (Figure 4-14D). Alveolar macrophages also produced TNF in response to IL-1 
treatment (Figure 4-15A). Importantly, this response was dependent on expression of 
the IL-1R, as alveolar macrophages from IL-1R-/- mice did not produce TNF when 
treated with IL-1 (Figure 4-15B). Inflammatory monocytes were unresponsive to IL-1 
treatment as measured by TNF production and CD86 expression (Figure 4-16). We were 
also unable to see increased CD86 expression in response to LPS on inflammatory 
monocytes, suggesting that inflammatory monocytes may not express CD86 ex vivo 
(Figure 4-16A). Together, these data indicate that some innate cell populations, such as 
dendritic cells and alveolar macrophages, may directly respond to IL-1 signaling during 
L. pneumophila infection in a cell-intrinsic manner. Other cells types, however, do not 
respond to IL-1 and may require either additional signals to produce cytokines or require 
a intermediate cell type to respond to IL-1. 
 
Conclusion 
Cells targeted by the T4SS of L. pneumophila were poor producers of the cytokines 
TNF, IL-6, IL-12p40, and fail to increase expression of CD86 upon infection. Instead, 
uninjected, bystander cells produced the majority of these cytokines in vitro and in vivo. 
Injected cells were still able to produce IL-1α and IL-1β during infection and IL-1 
signaling was important in vivo for the production of cytokines by bystander cells 
including uninjected alveolar macrophages, neutrophils, inflammatory monocytes, and 
dendritic cells. The 7 currently known T4SS effectors that block protein translation were 
important for preventing TNF production in injected cells early, but not later during 
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infection in vitro. Deleting these effectors did not affect the production of IL-6 by injected 
cells, suggesting that other effectors or a host-driven response prevent IL-6 and late 
TNF production by injected cells. BMDMs did not respond to IL-1 stimulation in vitro and 
do not require IL-1R signaling to produce bystander cytokines. IL-1R-/- mice in vivo 
produced less TNF and IL-12 during L. pneumophila infection, but still produced a small 
amount of cytokine. Together, these data suggest that other mechanisms besides IL-1 
signaling drive bystander cytokine production. Both alveolar macrophages and BMDCs 
were able to produce TNF in response to IL-1 stimulation and BMDCs also increased 
expression of CD86. Inflammatory monocytes, however, did not respond to IL-1. Thus, 
IL-1 signaling is sufficient in some, but not all cell types shown to produce bystander 
cytokines in vivo. Together, these data detail a mechanism by which cells infected with a 
pathogen that blocks host protein synthesis are able to communicate to uninfected cells 
to initiate a protective immune response. 
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Figure 4-1. T4SS-injected and uninjected macrophages produce different cytokines in 
vitro. (A-D) Bone marrow-derived macrophages (BMDMs) were infected with Lp02 
strains of L. pneumophila for 4, 8, 12, or 16 hours. BMDMs were treated with brefeldin A 
and monensin starting at 3 hours prior to harvest. Cells were then loaded with CCF4-
AM, fixed, and then stained with antibodies against TNF (A), IL-6 (B), IL-1α (C), and IL-
1β (D). Plots show cytokine production at 16 hours post infection (PI). Line graphs show 
ΔflaA-infected macrophages where total frequency of cytokine producing cells as well as 
the contribution of injected and uninjected cells to cytokines are shown. N=3 wells per 
condition per timepoint. Graphs show mean ± SEM. Representative of 3 independent 
experiments. (E) BMDMs were infected with Lp02 ΔflaA L. pneumophila for 8 hours. 
Cells were then loaded with CCF4-AM and sorted based upon cleavage of the dye, or 
were collected after going through the sorter without separating the cells based on dye 
cleavage (bulk). Sorted cells were then lysed and relative abundance of transcripts for 
proinflammatory cytokines were assayed using RT-PCR. Bar graphs show mean relative 
abundance of 2 separate wells. Statistics represent the results of Tukey’s post test 
between ΔflaA uninjected and ΔflaA injected columns. Representative of 3 independent 
experiments. ***p<0.0005 
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Figure 4-2. IL-12p40 and CD86 are expressed by bystander cells during infection. (A) 
Bone marrow-derived macrophages (BMDMs) were infected with Lp02 strains of L. 
pneumophila at an MOI = 5 for 4, 8, 12, or 16 hours. BMDMs were treated with brefeldin 
A and monensin starting at 3 hours prior to harvest. Cells were then loaded with CCF4-
AM, fixed, and then stained with antibodies against IL-12p40. Plots show cytokine 
production at 16 hours post infection (PI). Line graph shows ΔflaA-infected macrophages 
where total = the total frequency of cells positive for the given cytokine. Injected and 
uninjected = the relative contribution of each subset of cells to the total frequency of 
cytokine positive cells. N=3 wells per condition per timepoint. Line graphs show mean ± 
SEM (B) Cells infected as in (A) were harvested 8 hours PI, loaded with CCF4-AM and 
stained for CD86. Bar graph shows mean ± SEM. 
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Figure 4-3. Type IV secretion system effectors that block protein translation inhibit early 
TNF production in injected cells. BMDMs were treated with LPS or infected with Lp02 
WT, ΔdotA, ΔflaA, Δ5, or Δ7ΔflaA strains of L. pneumophila at an MOI = 5, infected for 
the indicated amount of time, loaded with CCF4-AM, and stained for ICS. (A & B) 
Representative flow plots showing TNF production 4 (A) or 16 (B) hours PI. The 
frequency of TNF-producing cells and the geometric MFI (gMFI) of TNF-producing-
injected cells are quantified in (D) for 4 hours and (E) for 16 hours. (C) Plots showing IL-
6 production at 16 hours PI. The frequency of IL-6-producing injected cells is quantified 
in (F). Representative of 2 independent experiments. Graphs show individual wells and 
mean. ANOVA was performed and statistics show significance between Δ5 and WT or 
Δ7ΔflaA and ΔflaA as determined by Tukey post test. *p<0.05, **p<0.005, ***p<0.0005, 
ns=not significant. 
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Figure 4-4. Bystander alveolar macrophages and neutrophils produce TNF during L. 
pneumophila infection. Mice were infected and cells were harvested from the 
bronchoalveolar lavage and lung tissue, treated with BFA, loaded with CCF4-AM, 
stained, fixed and stained with an antibody against TNF. (A-D) Representative plots from 
alveolar macrophages (A) and neutrophils (C) collected from the BAL 24 hours PI and 
quantified in (B & D). Graphs show individual mice and mean from 3 pooled independent 
experiments. Graphs on far right show the relative contribution of uninjected and injected 
cells to TNF production from ΔflaA-infected mice. N=2-3 mice per group per experiment. 
Student’s T-tests were performed for total TNF producing cells between ΔdotA and ΔflaA 
infected mice. **p<0.005, ***p<0.0005. 
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Figure 4-5. T4SS-injected alveolar macrophages produce IL-1 during pulmonary 
infection. Mice were infected with 5x106 CFU of JR32 ΔdotA or ΔflaA L. pneumophila 
intranasally or given PBS. 24 hours PI, cells were harvested from the lung tissue, treated 
with BFA, loaded with CCF4-AM, stained, fixed and stained with an antibody against IL-
1α (A) and IL-1β (B). Representative plots are shown. N=2-3 mice per group. 
Representative of 2 independent experiments. 
  
In
je
ct
io
n 
(b
lu
e)
!
ΔdotA! ΔflaA!
0.216 0.0345
2.4297.3
0.154 0
4.5795.3
2.49 5.7
17.973.9
0.0977 0.0391
1.8798
0.181 0.0345
4.2595.5
3.56 4.49
25.566.5
Alveolar Macrophages!
PBS!
IL-1β!
IL-1α!
0.2! 0.1!
2.4!
0.2! 0!
4.6!
2.5! 5.7!
17.9!
0.1! 0.1!
1.9!
0.2! 0.1!
4.3!
3.6! 4.5!
25. !
7.3! 5.2! 3.9!
7.9! 95.4! 66.4!
In
je
ct
io
n 
(b
lu
e)
!
A!
B!
ΔdotA! ΔflaA!PBS!
Alveolar Macrophages!
82	  
 
Figure 4-6. Bystander alveolar macrophages and neutrophils from the lung produce TNF 
during infection. Alveolar macrophages (A) and neutrophils (C) were harvested from the 
lung tissue of infected mice and stained for TNF production. Representative flow plots 
are shown. Graphs show individual mice and mean from 3 pooled independent 
experiments. (B & D) Graphs on far right show the relative contribution of uninjected and 
injected cells to TNF production from ΔflaA-infected mice. N=2-3 mice per group per 
experiment. Student’s T-tests were performed for total TNF producing cells between 
ΔdotA and ΔflaA infected mice. ns=not significant, **p<0.005, ***p<0.0005.  
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Figure 4-7. Bystander inflammatory monocytes and conventional dendritic cells produce 
TNF and express CD86 during infection. Cells were harvested from the lung tissue of 
mice, treated with BFA, loaded with CCF4-AM, stained, fixed and stained with an 
antibody against TNF (A & B) or CD86 (C & D). Representative plots are shown. Graphs 
show individual mice and mean from 3 pooled independent experiments. Student’s T-
test were performed between ΔdotA and ΔflaA infected mice. **p<0.005, ***p<0.0005. 
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Figure 4-8. Alveolar macrophages and neutrophils do not express CD86 during infection. 
24 hours PI, cells were harvested from the lung tissue, treated with BFA, loaded with 
CCF4-AM, stained with an antibody against CD86, and fixed.  Representative plots for 
alveolar macrophages (A) and neutrophils (B) are shown. N=2-3 mice per group. 
Representative of 3 independent experiments. 
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Figure 4-9. IL-1 signaling induces cytokine production by bystander cells. Cells were 
harvested from the lungs of infected WT or Il1r1-/- (IL-1R-/-) mice, treated with BFA, 
loaded with CCF4-AM, stained, fixed and then stained with an antibody against TNF. 
Representative plots from alveolar macrophages (A & B) and conventional dendritic 
cells (C & D) are shown. Graphs show individual mice and mean pooled from 4 
independent experiments. (E) BAL fluid was collected from mice and cytokine levels 
were measured by ELISA. Graphs show individual mice and mean pooled from 3 
independent experiments. N=2-4 mice per group. Student’s T-test were performed 
between pooled groups. ns=not significant, *p<0.05, **p<0.005, ***p<0.0005. 
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Figure 4-10. IL-1 signaling leads to the expression of CD86 and TNF by bystander cells. 
Cells were harvested from the lungs of infected WT or Il1r1-/- (IL-1R-/-) mice, treated with 
BFA, loaded with CCF4-AM, stained with an antibody against TNF (A & B) or CD86 (C 
& D). Representative flow plots from various cell populations are shown. Graphs show 
individual mice and mean pooled from 4 independent experiments. N=2-4 mice per 
group. Student’s T-test were performed between pooled groups. *p<0.05, **p<0.005, 
***p<0.0005. 
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Figure 4-11. Lack of IL-1 signaling does not alter the production of TNF by avirulent L. 
pneumophila infection.  Cells were harvested from the lungs of infected WT or Il1r1-/- (IL-
1R) mice, treated with BFA, loaded with CCF4-AM, stained, fixed and stained with an 
antibody against TNF. Representative flow plots showing TNF production from 
inflammatory monocytes (A) or conventional dendritic cells (B) from the lung. Bar graphs 
on right show individual mice and pooled mean from 3 independent experiments. 
0.403 0.127
6.3893.1
0.19 0.0632
19.480.2
0.0447 0.0223
5.1894.8
0.172 0.115
6.793
0.0508 0.554
14.285.2
0.0377 0.199
42.357.5
6.14e-3 0.203
17.682.2
0.0773 0.211
17.881.9
WT!
In
je
ct
io
n 
(b
lu
e)
!
Conventional dendritic cells!
IL-1R-/-!
ΔdotA! ΔflaA! ΔdotA! ΔflaA!
0.4! 0.1!
6.4!
0.2! 0.1!
19.4!
0.1! 0.1!
5.2!
0.2! 0.1!
6.7!
0.1! 0.6!
14.2!
0.1! 0.2!
42.3!
0! 0.2!
17.6!
0.1! 0.2!
17.8!
A!
B!
TNF!
In
je
ct
io
n 
(b
lu
e)
!
TNF!
3.1! 80.3! 94.3! 93.1!
85.1! 57.4! .2! 81.9!
% TNF + cDCs B6 vs. IL1R
B6
 do
tA
B6
 fla
A
IL-
1R
-/-
 do
tA
IL-
1R
-/-
 fla
A
0
10
20
30
%
 T
N
F 
+
TNF + iMCs B6 vs. IL1R
B6
 do
tA
B6
 fla
A
IL-
1R
-/-
 do
tA
IL-
1R
-/-
 fla
A
0
20
40
60
80
100
%
 T
N
F 
+
Δ
do
tA
!
Δ
do
tA
!
Δ
fla
A!
Δ
fla
A!
WT! IL-1R-/-!
Δ
do
tA
!
Δ
do
tA
!
Δ
fla
A!
Δ
fla
A!
WT! IL-1R-/-!
%
 T
N
F 
+!
10!
20!
30!
20!
40!
60!
80!
10 !
%
 T
N
F 
+!
WT!
Inflammatory monocytes!
IL-1R-/-!
ΔdotA! ΔflaA! ΔdotA! ΔflaA!
88	  
 
Figure 4-12. Both IL-1α and IL-1β contribute to cytokine production during L. 
pneumophila infection. Mice were then infected with JR32 ΔflaA L. pneumophila 
intranasally. 24 hours PI, BAL and lungs were harvested and CFUs were plated for 
viable L. pneumophila from lung homogenates. Graphs show individual mice and mean. 
Statistics are one-way ANOVA with the stats representing the significance of the Tukey 
post-test between isotype mice and the groups of interest. ns=not significant, **p<0.05, 
**p<0.005, ***p<0.0005. 
 
  
1x106 JR32 ΔflaA inoculum, 24 hours PI
Iso
typ
e
α-
IL-
1α
α-
IL-
1β
α-
IL-
1α
/IL
-1β
0
100
200
300
TN
F 
(p
g/
m
L)
1x106 JR32 ΔflaA inoculum, 24 hours PI
Iso
typ
e
α-
IL-
1α
α-
IL-
1β
α-
IL-
1α
/IL
-1β
0
500
1,000
1,500
2,000
IL
-6
 (p
g/
m
L)
1x106 JR32 ΔflaA inoculum, 24 hours PI
Iso
typ
e
α-
IL-
1α
α-
IL-
1β
α-
IL-
1α
/IL
-1β
0
500
1,000
1,500
IL
-1
2p
40
 (p
g/
m
L)
1x106 JR32 ΔflaA inoculum, 24 hours PI
Iso
typ
e
α-
IL-
1α
α-
IL-
1β
α-
IL-
1α
/IL
-1β
103
104
105
106
107
C
FU
/g
 L
un
g
10 !
20 !
30 !
TN
F 
(p
g/
m
L)
!
IL
-6
 (n
g/
m
L)
!
0.5!
0.5!
1.0!
1.5!
IL
-1
2p
40
 (n
g/
m
L)
!
is
ot
yp
e!
1. !
1.5!
2. !
10 !C
FU
/g
 lu
ng
!
105!
10 !
10 !
α-
IL
-1
α!
α-
IL
-1
β!
α-
IL
-1
α!
+ 
IL
-1
β!
is
ot
yp
e!
α-
IL
-1
α!
α-
IL
-1
β!
α-
IL
-1
α!
+ 
IL
-1
β!
is
ot
yp
e!
α-
IL
-1
α!
α-
IL
-1
β!
α-
IL
-1
α!
+ 
IL
-1
β!
is
ot
yp
e!
α-
IL
-1
α!
α-
IL
-1
β!
α-
IL
-1
α!
+ 
IL
-1
β!
ns! *! **! ***!ns! ns! ns! ns! ns! ns! *! **!
89	  
 
Figure 4-13. Bone marrow-derived macrophages are unresponsive to IL-1 treatment. (A) 
BMDMs from WT or IL-1R-/- mice were left untreated with or infected with the Lp02 ΔflaA 
strain of L. pneumophila at an MOI = 5, infected for 4 hours, loaded with CCF4-AM, and 
stained for TNF. (B) BMDMs from WT or IL-1R-/- mice were infected with the Lp02 ΔdotA 
or ΔflaA strain of L. pneumophila at an MOI = 5 and IL-6 production was measured by 
ELISA 24 hours PI. (C) BMDMs were treated with 100-100,000 pg/mL of recombinant IL-
1α, IL-1β, or IL-1α and IL-1β combined, or 100ng/mL LPS for 24 hours. TNF and IL-6 
were then measured by ELISA. (D) NIH/3T3 cells were treated with 10-100ng/mL of 
recombinant IL-1α, IL-1β, or IL-1α and IL-1β combined, or 100ng/mL LPS for 24 hours 
and IL-6 was measured by ELISA. Graphs show mean ± S.E.M. Representative of two 
independent experiments. 
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Figure 4-14. Bone marrow-derived dendritic cells produce cytokines and express CD86 
in response to IL-1 treatment. (A & B) BMDCs were treated with LPS, PAM3CSK4, or 
100ng/mL IL-1α, IL-1β, or both for 6 hours. 3 hours prior to harvest, cells were treated 
with BFA. Cells were then fixed and stained for CD86 (A) or TNF (B). Representative 
flow plots are shown. (C) Quantification of plots shown in (A & B). (D) BMDCs were 
treated as in (A & B) for 24 hours. Supernatants were then harvested and TNF and IL-6 
production were measured by ELISA. Graphs show individual wells and mean. ANOVA 
was performed and statistics show significance between untreated cells and the 
appropriate condition as determined by Tukey post test. *p<0.05, **p<0.005, 
***p<0.0005, ns=not significant. 
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Figure 4-15. Alveolar macrophages produce TNF in response to IL-1 treatment. (A & B) 
Alveolar macrophages from WT (A) or IL-1R-/- (B) mice were isolated and seeded in 
culture at 10,000 cells per well in 150µl DMEM + 10% FBS. Cells were then treated with 
100ng/mL LPS, IL-1α, IL-1β, or both for 6 hours. 3 hours prior to harvest, BFA was 
added to the wells. Cells were then fixed and then stained for TNF. (C) Quantification of 
(A & B). Graphs show mean of two independent mice. 
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Figure 4-16. Inflammatory monocytes do not respond to IL-1 treatment. (A & B) 
inflammatory monocytes were isolated from the bone marrow of WT (A) or IL-1R-/- (B) 
mice. Cells were then treated with 100ng/mL LPS, IL-1α, IL-1β, or both for 6 hours. 3 
hours prior to harvest, BFA was added to the wells. Cells were then fixed and then 
stained for TNF and CD86. (C) Quantification of (A & B). (D) Gating strategy for isolated 
inflammatory monocytes. Monocytes are Ly6Chi, CD11bint to CD11bhi and do not express 
Ly6G. Monocytes were 90-95% pure. Graphs show mean of two independent mice. 
Representative of two independent experiments. 
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CHAPTER 5 
DISCUSSION 
 
A. Alveolar macrophages and neutrophils are targeted by the type IV secretion 
system of L. pneumophila 
Legionella pneumophila uses its T4SS to inject a large number of effector proteins into 
the cytosol of host phagocytes (Chen et al., 2010). The T4SS is necessary for 
intracellular replication and pathogenesis as L. pneumophila mutants lacking a functional 
T4SS fail to establish a replicative niche and do not cause pathology in mice (Barry et 
al., 2013; LeibundGut-Landmann et al., 2011; Marra et al., 1992; Roy et al., 1998). In 
addition to being required for L. pneumophila pathogenesis, T4SS activity potently 
activates multiple cytosolic immunosurveillance pathways (Casson and Shin, 2013; 
Losick and Isberg, 2006; Moltke et al., 2013; Shin et al., 2008). Thus, cells that interact 
with L. pneumophila and receive T4SS-translocated effectors serve as a potential 
replicative niche, but may also contribute to the immune response against L. 
pneumophila. However, the precise identity of such cells is unknown. I, therefore, set out 
to identify host cells that receive T4SS-translocated effectors during infection with L. 
pneumophila.  BlaM reporter systems have been used during in vivo infection with 
Yersinia pseudotuberculosis (Harmon et al., 2010; Maldonado-Arocho et al., 2013), 
Yersinia pestis (Pan et al., 2009; Pechous et al., 2013), Yersinia entercolitica (Köberle et 
al., 2009), Salmonella typhimurium (Geddes et al., 2007; Yoon et al., 2011), and 
Pseudomonas aeruginosa (Diaz and Hauser, 2010; Kung et al., 2012) to detect the 
translocation of effectors into host cells by the type III and type IV secretion systems. In 
chapter 3, I demonstrate that by using β-lactamase (BlaM) translationally fused to the 
T4SS-translocated effector protein RalF, I can successfully track injection by the T4SS 
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into host cells during both in vitro and in vivo infection, and I describe the first use of this 
BlaM reporter during in vivo pulmonary infection with L. pneumophila. 
 
I observed robust T4SS-mediated injection into alveolar macrophages at four hours post 
infection, consistent with previous observations that these cells are the primary cell type 
infected by L. pneumophila during pulmonary infection in human patients (Nash et al., 
1984). At later time points post infection, I find that in addition to alveolar macrophages, 
a large number of the cells injected by L. pneumophila in vivo are neutrophils (Figure 5-
1). This is likely due to the influx of neutrophils into the lungs and airway space during 
infection (Ang et al., 2012; Berrington et al., 2010; Brieland et al., 1994; Frutuoso et al., 
2010; Winn and Myerowitz, 1981; Winn et al., 1978). Other researchers have shown that 
neutrophils contain intracellular L. pneumophila in a non-permissive mouse model of 
pulmonary infection, but it was not examined whether L. pneumophila could survive 
within neutrophils or whether neutrophils are capable of receiving T4SS-translocated 
effectors (LeibundGut-Landmann et al., 2011). In vitro studies have suggested that 
Legionella species are resistant to the highly bactericidal activity of neutrophils but 
cannot replicate within these cells (Horwitz and Silverstein, 1981; Weinbaum et al., 
1983). Thus, I initially presumed that although neutrophils might be injected during in 
vivo infection, the majority of bacteria would eventually be cleared due to a failure to 
replicate in these cells, and I would not be able to detect any appreciable number of 
viable bacteria within these cells. I obtained viable L. pneumophila in numbers that 
roughly corresponded with the frequency of injection seen with our reporter system, 
suggesting that L. pneumophila can survive within neutrophils during in vivo infection. 
Unexpectedly, given the large number of neutrophils that enter the lung, the total number 
of L. pneumophila CFUs harbored by neutrophils is greater than the total number of L. 
pneumophila CFUs found within the alveolar macrophage population 24 and 48 hours 
95	  
PI. Given the large numbers of infected neutrophils that I observed, it would be of 
interest to determine whether L. pneumophila could establish an ER-derived vacuole 
and successfully replicate within neutrophils, as this could represent another intracellular 
niche for L. pneumophila. Most bacteria are not thought to survive or replicate within 
neutrophils, but there are a few exceptions, including Neisseria gonorrheae (Simons et 
al., 2005), Anaplasma phagocytophilum (Chen et al., 1994; Ohashi et al., 2002), and 
pathogenic Escherichia coli (Nazareth et al., 2007). 
 
B. Non-phagocytic cells are not targeted by L. pneumophila for injection 
As I was only able to detect robust T4SS-dependent injection into alveolar macrophages 
and neutrophils, I conclude that phagocytic cells in the airway space are the primary 
recipients of T4SS-translocated effectors during pulmonary L. pneumophila infection. 
Whether or not T4SS-injected cells survive infection and traffic to other organs including 
lymph nodes is unknown. However, previous studies have reported that alveolar 
macrophages do traffic to lymph nodes when given allergic stimuli (Kirby et al., 2009). 
Thus, it would be of interest to investigate whether T4SS-injected alveolar macrophages 
either induce adaptive immunity or participate in the dissemination of infection to other 
organs (Kirby et al., 2009). Surprisingly, I was unable to detect T4SS-injected 
conventional dendritic cells during in vivo infection. Dendritic cells undergo rapid 
apoptosis in response to L. pneumophila T4SS activity (Nogueira et al., 2009), which 
could account for why I do not detect as robust injection in dendritic cells as compared to 
macrophages in vitro and in vivo, although the number of DCs increased during 
infection. Further experiments to determine whether injection could be detected in DCs 
lacking apoptotic regulators such as BAX and BAK, thus, resistant to L. pneumophila-
induced apoptosis, could be fruitful. However, C57BL/6-derived macrophages undergo 
rapid pyroptosis in response to WT L. pneumophila infection, yet I still detect injection in 
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this cell type, suggesting that L. pneumophila-induced cell death is an insufficient 
explanation to account for the lack of detectable injection in DCs (Case et al., 2009). 
Given that phagocytosis is required for T4SS-mediated translocation, another possibility 
is that dendritic cells in the lung may not efficiently phagocytose L. pneumophila 
(Charpentier et al., 2009). Alternatively, pulmonary dendritic cells and L. pneumophila 
may be spatially separated during in vivo infection. Infection may occur primarily in the 
airway space itself, and thus only neutrophils and alveolar macrophages are available 
targets for translocation. To what extent infection occurs in the lung tissue itself has not 
been fully investigated. Histological studies would help elucidate the temporal and 
spatial constraints present during L. pneumophila infection. 
 
Although I could only detect T4SS-mediated translocation in pulmonary phagocytic cells, 
other infectious models using different pathogens have observed translocation into a 
larger variety of cells. For instance, studies using an intraperitoneal model of Yersinia 
pseudotuberculosis demonstrate translocation mediated by the type three secretion 
system into splenic phagocytes as well as splenic B and T cells (Köberle et al., 2009). In 
an infectious model using the parasite Toxoplasma gondii that does not encode a 
secretion system but does inject proteins into infected cells, injects phagocytic cells, 
non-immune cells, and even injects neurons (Koshy et al., 2012). Interestingly, in the T. 
gondii model, injection is detected in cells that do not harbor intracellular parasites. I did 
not assay whether L. pneumophila also injects cells it does not invade, but the data 
obtained via imaging flow cytometry suggest that nearly all injected cells contain L. 
pneumophila and it has not been demonstrated that L. pneumophila can egress from an 
infected host cells without subsequent death of the cell. 
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The experiments performed in this study looked at cells targeted by the T4SS of L. 
pneumophila in immunocompetent hosts. Infections of immunocompromised mice, such 
as mice lacking IFNγ and MyD88, result in higher bacterial burdens, bacterial 
dissemination to peripheral organs, and sometimes death of the host organism (Archer 
et al., 2009; Spörri et al., 2006). Higher bacterial burdens would require increased 
bacterial burdens in alveolar macrophages and neutrophils either in the frequency of 
infected cells, or an increase in the number of viable bacteria in a single cell. However, 
MyD88-deficient mice fail to mount an appropriate immune response and have delayed 
and reduced recruitment of cells such as neutrophils to the site of infection (Archer and 
Roy, 2006). Whether other cells types, such as epithelial or dendritic cells, harbor viable 
L. pneumophila in immunocompromised hosts remains to be seen. For dissemination, 
other cell types, such as tissue resident macrophages in the spleen and liver, may 
harbor viable L. pneumophila; however, I did not look at a model of dissemination. It will 
be important to investigate targeting of the T4SS in these models as they mimic the 
increased bacterial burdens and dissemination seen in immunocompromised human 
patients, which would lead to a better understanding of clinical disease (Lowry and 
Tompkins, 1993). 
 
Using the A549 alveolar epithelial cell line during in vitro infection, I detected a low 
percentage of T4SS-injected cells under conditions using both nonmotile and motile 
bacteria. Although the L. pneumophila were centrifuged onto A549 cells in vitro, motility 
may alter the contact between host cells and L. pneumophila in a way that facilitates 
bacterial entry. Many researchers utilize A549 cells as a model for L. pneumophila 
infection and can detect productive bacterial replication within these cells (Maruta et al., 
1998). However, these studies either use higher MOIs than those used in this study or 
opsonize the bacteria prior to infection. These discrepancies in technique may explain 
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why I am unable to detect higher percentages of injected alveolar epithelial cells during 
in vitro infection. I was also unable to detect robust T4SS-dependent translocation into 
airway epithelial cells or other non-phagocytic cells during in vivo infection. Utilizing a 
non-permissive model of C57BL/6 mice infected with WT L. pneumophila, other 
researchers found that lung epithelial cells did not appear to contain L. pneumophila 
(LeibundGut-Landmann et al., 2011). Our data argue against a direct role for airway 
epithelial cells in cytosolic sensing of L. pneumophila T4SS activity during pulmonary 
infection. Airway epithelial cells have been shown to indirectly respond to L. 
pneumophila infection by producing the chemokine CXCL1 in response to IL-1 produced 
by macrophages (LeibundGut-Landmann et al., 2011).  
 
C. Alveolar macrophages and neutrophils produce cytokines in response to 
virulent L. pneumophila infection 
I found that alveolar macrophages secreted TNF and IL-1α four hours PI in vivo. Both 
TNF and IL-1α are important for controlling L. pneumophila infection. The 
inflammasome-regulated cytokines IL-1α and IL-1β are critical for neutrophil recruitment 
to the lung airway during L. pneumophila infection through a mechanism involving the IL-
1R-dependent induction of CXCL1 from alveolar epithelial cells (Barry et al., 2013; 
Casson et al., 2013; LeibundGut-Landmann et al., 2011). It is unclear whether other 
cells in the lung produce cytokines so early during infection. However, as IL-1α 
production in vivo is T4SS-dependent and I could only detect T4SS injection into 
alveolar macrophages at 4 hours post-infection, our data would suggest that during the 
first few hours of infection, alveolar macrophages are the primary source of IL-1α, 
consistent with another study indicating that hematopoietic cells are an early source of 
IL-1α (Barry et al., 2013). 
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At 24 hours post-infection, I found that neutrophils recruited to the lungs of mice infected 
with ΔflaA L. pneumophila secrete the proinflammatory cytokines TNF and IL-1α, but not 
mice infected with ΔdotA L. pneumophila. These data indicate that, like alveolar 
macrophages, neutrophils secrete cytokines in response to cytosolic sensing of T4SS-
translocated bacterial products. It has previously been reported that neutrophils can 
secrete cytokines, but the signaling pathways that control cytokine production and 
secretion in neutrophils are poorly understood. Neutrophils are known to release TNF-
containing granules in response to a variety of stimuli, including various bacterial 
infections (Bennouna et al., 2003; Tsuda et al., 2004). Previous research has 
demonstrated that neutrophils can release IL-1α in a model of sterile inflammation or IL-
1β independently of caspase-1 and caspase-11 in a mouse model of arthritis and during 
bacterial infection (Guma et al., 2009; Karmakar et al., 2012; Rider et al., 2011). In an 
intravenous infection model of L. pneumophila infection, splenic neutrophils were shown 
to produce IL-18, an IL-1 family cytokine, which induces IFN-γ production from NK cells 
(Spörri et al., 2008). Previous studies demonstrated that IL-1α secretion is regulated by 
both inflammasome-dependent and –independent pathways during in vivo WT L. 
pneumophila infection (Barry et al., 2013; Casson et al., 2013), but it is unknown which 
of these pathways are used by macrophages and neutrophils to secrete IL-1α in vivo. It 
would be of interest to determine the host and bacterial components required for release 
of IL-1 and other cytokines from macrophages and neutrophils in response to in vivo 
infection with L. pneumophila. 
 
Overall, our study is the first to define the cell types that receive T4SS-translocated 
effectors during pulmonary L. pneumophila infection. I reveal that both alveolar 
macrophages and neutrophils receive translocated effector proteins, harbor viable 
bacteria, and respond to infection by producing inflammatory cytokines. Collectively, our 
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data indicate that alveolar macrophages and neutrophils not only provide an intracellular 
reservoir for L. pneumophila, but also provide an important source of proinflammatory 
cytokines that contribute to a successful host immune response during pulmonary L. 
pneumophila infection. 
 
D. Bystander cytokine production by uninjected cells 
Infection with L. pneumophila leads to robust pro-inflammatory cytokine production. 
Much of this cytokine response is dependent on cytosolic sensing of T4SS activity 
(Fontana et al., 2011; Shin et al., 2008), although paradoxically, several T4SS effector 
proteins introduced into infected cells potently block host protein synthesis (Barry et al., 
2013; Belyi et al., 2006; 2008; Fontana et al., 2012; Ivanov and Roy, 2013; McCusker et 
al., 1991; Shen et al., 2009). In chapter 4, I set out to examine how a robust cytokine 
response is generated despite this translational block. Our data indicate that cells 
receiving T4SS effectors can synthesize IL-1α and IL-1β, but are poor producers of the 
key immune proteins TNF, IL-6, IL-12, and CD86. Instead, bystander immune cells that 
have not received T4SS effectors produce the majority of these immune signals in vitro 
and in vivo. Furthermore, IL-1 signaling is required for robust production of TNF and 
other immune proteins by bystander cells. Thus, our data suggest that detection of 
PAMPs is inadequate to trigger a robust immune response in bystander cells. Instead, a 
cytokine released by infected cells signals to uninfected bystander cells to bypass the 
pathogen-imposed translational block and enable production of a robust inflammatory 
cytokine response.  
 
Why TLR signaling alone is insufficient to drive cytokine responses in vivo is a 
conundrum. In vitro and in vivo, the use of purified TLR ligands can induce robust 
cytokine production and cellular recruitment to the site of delivery. It must be noted, 
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however, that many LPS instillation protocols use an amount of LPS that can equate to a 
number of bacteria on the order of 1010 CFUs (if 0.1ng of LPS = 105 CFU of E. coli, then 
10-100µg of LPS would be equivalent to nearly one million times more bacteria) (Arndt 
et al., 2005; Raetz, 1986; Szarka et al., 1997). Assuming equivalent calculations for L. 
pneumophila, this dose is equal to a 10,000-fold increase in the number of L. 
pneumophila we detect even during the peak of virulent pulmonary infection. Thus, TLR 
signaling can induce cytokine production alone, but perhaps only in response to large 
amounts of TLR ligands. L. pneumophila LPS is a poor stimulator of TLR4 (Lettinga et 
al., 2002) and infection itself does not appear to induce the required amount of TLR 
stimulation to drive cytokine responses in vivo.  
 
Beyond the total amount of TLR ligands present, tolerance to TLR-mediated signaling, 
specifically tolerance to LPS or endotoxin is a well-described, multi-faceted phenomenon 
(Biswas and Lopez-Collazo, 2009). Upon repeated, low exposure to LPS, cells exhibit 
milder and milder cytokine and recruitment responses. This tolerance is mediated by a 
variety of mechanisms, including increased expression of negative regulators of TLR 
signaling (Liew et al., 2005; Nimah et al., 2005), decreased expression of TLRs and 
downstream signaling pathways (Biswas and Tergaonkar, 2007; Medvedev et al., 2000), 
and changes in the chromatin containing proinflammatory genes (Chan et al., 2005; 
Foster et al., 2007). Cells of the innate immune system patrol barrier sites and cells such 
as alveolar macrophages are exposed to the outside of the body, these cells may be in 
contact with a low, constant level of TLR ligands that may induce and maintain a state of 
tolerance in these cells. Indeed, a role for TLR tolerance in maintaining intestinal 
homeostasis has been demonstrated (Abreu et al., 2002; Singh et al., 2005). Likewise, 
research has demonstrated that innate immune cells of the lamina propria do not 
produce TNF or IL-6 in response to TLR stimulation, suggesting that cells at other barrier 
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sites may behave in a similar fashion (Franchi et al., 2012). As these cells may be 
tolerized, other signals such as IL-1 may be required either to act synergistically with 
TLR and other PRR signaling to overcome this tolerance or may sensitize innate 
immune cells to the presence of bacterial PAMPs. It would be of interest to investigate 
whether TLR signaling is enhanced by the presence of IL-1. Treating cells with purified 
TLR ligands or avirulent T4SS-deficient L. pneumophila in the presence or absence of 
IL-1 will help determine whether synergistic effects occur with this combination of stimuli. 
 
E. Injected cells produce IL-1α and IL-1β during protein translations inhibition  
Cells targeted by the T4SS of L. pneumophila still transcribe many proinflammatory 
genes, such as Il6, Tnf, Il1a, and Il1b. These cells, however, are unable to translate IL-6 
and TNF during virulent infection, but are able to translate IL-1α and IL-1β (Figure 5-2). 
The inability of injected cells to produce TNF is partly due to effector-mediated protein 
translation inhibition, as cells injected by mutants of L. pneumophila lacking either 5 or 7 
of the protein translation inhibiting effectors were able to produce TNF during infection. 
At later times, however, injected cells infected with these mutants produced just as little 
TNF and IL-6 as their WT infected counterparts. These data indicate that part of the 
inability of injected cells to produce certain proinflammatory cytokines is effector driven. 
Why injected cells are unable to produce TNF and IL-6 later in infection remains to be 
elucidated. Given the highly redundant nature of the T4SS effectors, other effectors that 
inhibit host protein translation may exist. Alternatively, later protein translation may be a 
host-driven response depending on mTOR or some other stress-induced pathway. 
Future experiments will focus on altering mTOR signaling during L. pneumophila 
infection and assaying for cytokine production from infected cells to determine whether a 
mTOR-mediated host response is responsible for the block in protein translation. 
Alternatively, infections using T4SS-deficient L. pneumophila in combination with mTOR 
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inhibitors such as rapamycin may elucidate whether translation inhibition during L. 
pneumophila infection is host cell-driven. 
 
It is intriguing that infected cells are able to effectively translate IL-1 but not other 
cytokines that I assayed. Unlike conventional cytokines, IL-1α and IL-1β are translated 
by cytosolic ribosomes in a pro-form and are secreted via an unknown mechanism 
requiring the activation of the inflammasome (Rathinam et al., 2012; Stevenson et al., 
1992). MyD88 and altered mTOR signaling participate in the selective translation of 
proinflammatory cytokines during L. pneumophila infection via unknown or poorly 
understood mechanisms (Asrat et al., 2014; Brieland et al., 1995; 1998; Byrd and 
Horwitz, 1989; Casson et al., 2013; Copenhaver et al., 2014; Ivanov and Roy, 2013; 
LeibundGut-Landmann et al., 2011; Spörri et al., 2006). Whether MyD88 and altered 
mTOR signaling occurs directly in infected cells or influences cytokine production in 
bystander cells remains to be determined. Previous research has suggested that mRNA 
abundance may determine which transcripts are selected for translation when translation 
is inhibited (Asrat et al., 2014; Ivanov and Roy, 2013). My data, however, do not 
demonstrate a large difference in the total abundance between transcripts that are 
translated (Il1a, Il1b) and transcripts that are not (Il6, Tnf). Thus, it is unlikely that mRNA 
fully explains the mechanism of selective translation. 
 
During periods of protein synthesis blockade, not all proteins remain untranslated. Host 
cells target key mRNAs to ribosomes during protein synthesis inhibition induced during 
the unfolded protein response, which allows for at least minimal translation of key 
proteins. Targeting of key mRNAs to the ribosome during protein synthesis inhibition 
requires the presence of unique 5’ and 3’ untranslated regions (UTR) on the mRNA of 
interest (Vivinus et al., 2001). Host cells also segregate cytosolic non-essential mRNAs 
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into structures called stress granules (Thomas et al., 2011). These granules associate 
mRNAs with the mRNA degradation machinery, depleting the cell of non-essential 
mRNAs to translate. Sequestration and clearance of non-key mRNAs prevents their 
translation and decreases the competition key mRNAs have to overcome to be 
translated. Thus, even when global protein production is decreased, cells can 
preferentially target certain mRNAs for translation. It is known that the mRNAs encoding 
the proinflammatory cytokines IL-6 and TNF have AU-rich UTRs, but these UTRs have 
been implicated in the instability of these mRNAs (Villarino et al., 2011). In contrast, the 
mRNA encoding IL-1β has been previously shown to be more stable than the mRNA for 
TNF (Chen et al., 2006). This raises the possibility that inflammasome-related mRNAs, 
due to their unique UTR sequences, are preferentially translated during L. pneumophila 
infection.  Future work will investigate whether certain cytokine mRNAs, such as IL-1α 
and IL-1β contain regulatory elements in their UTRs that spare them from the effects of 
global suppression of protein synthesis and if mRNA regulation of IL-1 is important for its 
production during infection with L. pneumophila.  
 
F. IL-1 induces TNF production and CD86 expression in dendritic cells and 
alveolar macrophages 
My data indicate that uninfected bystander cells play a critical role in host defense during 
L. pneumophila infection. These cells both directly or indirectly sense the IL-1 released 
by infected cells and respond by producing TNF and other immune proteins. IL-1 
signaling utilizes MyD88 and leads to the activation of NF-κB as well as MAPK. In 
epithelial cells, IL-1 induces IL-6 production as well as chemokine production. TNF is not 
induced in response to IL-1 by epithelial cells; however. These data indicate that 
epithelial cells are incapable of producing TNF to a variety of stimuli that induce the 
production of other cytokines. IL-1-induced TNF production is not a well-characterized 
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phenomenon, but human PBMCs have been shown to produce TNF in response to 
treatment with IL-1α as well as IL-1β (Kim et al., 2013). As these experiments were 
performed with whole PBMCs, it is unclear which cell types specifically respond to IL-1, 
but it implies at least one cell type expresses the IL-1R and can produce TNF in 
response to IL-1 signaling. 
 
Expression of the IL-1R in vivo is poorly characterized. Epithelial cells and T cells are 
known to express the IL-1R and the response to IL-1 stimulation is best characterized in 
these cell types (Dinarello, 1996). Bone marrow-derived macrophages fail to respond to 
IL-1 either alone or in combination with other signals. Bone marrow-derived 
macrophages also do not express TLR5 and do not respond to extracellular flagellin, 
even though various subsets of macrophages in vivo do (Means et al., 2003). I detected 
a low, but evident production of TNF by alveolar macrophages in response to IL-1 
stimulation ex vivo. It is possible that ex vivo culture diminishes the responsiveness of 
cells to IL-1 stimulation, although cells were able to produce robust amounts of TNF in 
response to LPS, ruling out broad inability of the cells to function. These data indicate 
that alveolar macrophages express the IL-1R. IL-1 stimulation is known to activate 
alveolar macrophages in vivo, but TNF production in response to IL-1 has never been 
assayed until this study (Hussell and Bell, 2014). Only a small frequency of alveolar 
macrophages produced TNF in response to IL-1 stimulation ex vivo. It is unclear whether 
all alveolar macrophages express the IL-1R ubiquitously or if only a subset of cells 
express the receptor. Although an antibody exists to stain for the IL-1R1 (CD121a) chain 
of the IL-1R, staining for this receptor in vivo has proved difficult and not definitive in 
mice (data not shown), but staining of human T cells demonstrates heterogeneous IL-1R 
expression on subsets of activated T cells (Dower et al., 1986; Lee et al., 2010). 
Likewise, it is unclear whether TLR signaling or some other infectious cue can induce IL-
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1R expression on alveolar macrophages. Activation of T cells can increase expression of 
the IL-1R on the surface, suggesting that similar activation of other cell types might also 
result in increased receptor expression and responsiveness to IL-1 (Lee et al., 2010). 
Future work will focus on assaying IL-1R expression on various innate immune cell types 
during L. pneumophila infection to address whether receptor expression is altered during 
infection. 
 
Bone marrow-derived dendritic cells, like alveolar macrophages, also responded to IL-1 
stimulation. These cells produced TNF and increased surface expression of CD86. 
Again, only a small portion of dendritic cells produced TNF in vitro. These data suggest 
that bone marrow-derived dendritic cells express the IL-1R at a resting state. It would be 
of interest to determine whether dendritic cells from the lung or other organs also 
express the IL-1R and respond in a similar fashion. Of note, dendritic cells transferred 
into the lungs of mice increase expression of CD86 upon repeated intranasal treatment 
with IL-1 which indicates that dendritic cells may express the IL-1R and are activated 
upon IL-1 stimulation (Pang et al., 2013). 
 
Inflammatory monocytes isolated from the resting bone marrow pool did not respond to 
IL-1 stimulation ex vivo. This is in stark contrast to the massive reduction in TNF-
producing monocytes in IL-1R-/- mice. It is still unclear whether inflammatory monocytes 
express the IL-1R at a basal state or express it during infection or tissue egress. 
Experiments in this study use bone marrow-derived monocytes, which are considered a 
resting pool of monocytes. Many recent advances in the description and analysis of 
inflammatory monocytes have described several subsets of monocytes that express 
different chemokine receptors, including CCR2 and CX3CR1 and vary in their functional 
capacities (Hohl et al., 2009; Narni-Mancinelli et al., 2011; Yang et al., 2014). Thus, 
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future work should determine the phenotype of the inflammatory monocytes recruited to 
the lung during L. pneumophila infection as well as their expression of various receptors, 
including IL-1R. If inflammatory monocytes do express the IL-1R, then their lack of a 
response to IL-1 stimulation alone could indicate that they require additional signals, 
such as TLR signaling or chemokines, to produce cytokines. It is also unclear whether 
inflammatory monocytes are responding directly to IL-1R signaling in a cell-intrinsic 
manner, or are responding to a signal produced in response to IL-1 made by another cell 
type. Chimeric mice, in which a mix of WT and IL-1R-deficient innate immune cells exist, 
will be useful to determine the direct and indirect role of IL-1 signaling on inflammatory 
monocytes as well as other innate immune cell types. There is some evidence for this 
cell-extrinsic response to IL-1 as neutrophils are recruited to sites of inflammation by 
chemokine production from epithelial cells induced by IL-1 signaling. Thus, we find that 
IL-1R signaling is necessary, but not sufficient, to drive optimal cytokine production from 
monocytes during L. pneumophila infection. 
 
I was unable to determine a role for IL-1 signaling directly on neutrophils during infection. 
Neutrophils were originally thought to migrate towards IL-1 and do express some 
inducible level of IL-1R (Fasano et al., 1991). However, instead of migrating directly in 
response to IL-1, neutrophils respond to the aforementioned chemokine products of IL-1 
signaling on epithelial cells (Tateda et al., 2001b). Neutrophils are a source of IL-1α 
during L. pneumophila infection, but unfortunately, we were unable to induce cytokine 
production from neutrophils isolated from the resting bone marrow pool ex vivo in 
response to any stimuli, including LPS (data not shown). It is possible that neutrophils do 
respond to IL-1, but as my culturing systems are unable to demonstrate neutrophil 
activation in response to any stimuli, I am currently unable to determine a direct role IL-1 
signaling on neutrophils during infection. 
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Together, these data indicate that in certain cell types, IL-1 signaling is sufficient to drive 
a low-level cytokine response. However, not all cells are activated directly by IL-1 and IL-
1 does not induce robust cytokine production. Yet, a lack of IL-1R affects cytokine 
production from neutrophils, alveolar macrophages, dendritic cells, and inflammatory 
monocytes. These data argue for a complex model of IL-1 signaling in vivo during L. 
pneumophila infection (Figure 5-3). It is unclear what other signaling pathways might be 
important for bystander cytokine production in vivo. 
 
Unlike other models, my data indicate IL-1 signaling is partially required for the 
bystander cytokine response to L. pneumophila in vivo. There are multiple possible 
benefits to regulating cytokine production in this way. First, it ensures the production of 
pro-inflammatory cytokines during infection with a pathogen that limits host protein 
translation. Second, it may be a strategy that the immune system uses to avoid 
inappropriate responses to avirulent bacteria and instead respond only to virulent 
pathogens when it encounters a second signal, such as IL-1, that is specifically released 
in response to virulent pathogens (Fontana and Vance, 2011; Franchi et al., 2012). 
Third, cytokine production by bystander cells may provide a means of amplifying early 
immune signals, allowing for a more rapid and robust response. Bystander activation is 
likely to be a common strategy employed by the immune system for overcoming 
pathogen virulence mechanisms, and multiple mechanisms may exist for activating 
bystander cells by different cell types (Ablasser et al., 2013; Dolowschiak et al., 2010; 
Dreux et al., 2012; Kasper et al., 2010; Patel et al., 2009). Notably, during influenza A 
virus infection, IL-1 signaling activates bystander dendritic cells and enables subsequent 
priming of naïve CD8+ T cells (Pang et al., 2013). This study, along with our finding that 
uninfected bystander cells upregulate the costimulatory molecule CD86 (Figures 3 & 
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S5), has implications for understanding how a T cell response is generated during L. 
pneumophila infection. This implies that bystander cells may be key antigen presenting 
cells, perhaps following uptake of dead or dying infected cells (Trunk and Oxenius, 2012; 
Yrlid and Wick, 2000). 
 
Our findings also elucidate another critical function for IL-1 in early innate immune 
defense. In addition to the well-established role of IL-1 in eliciting production of 
neutrophil-attracting chemokines and the subsequent recruitment of neutrophils to the 
site of infection (Barry et al., 2013; Casson et al., 2013; LeibundGut-Landmann et al., 
2011; Mascarenhas et al., 2015), my data indicate that IL-1 mediates production of 
cytokines by bystander innate immune cells (Figure 4-9 & 4-10). Immune signals other 
than IL-1 also likely contribute to T4SS-dependent proinflammatory cytokine production 
in vivo, as IL-1 signaling is required for the maximal production of TNF and IL-12, but is 
dispensable for IL-6 production during L. pneumophila infection (Figure 4). The nature of 
these other immune signals and whether they can compensate for the absence of IL-1 in 
certain infection settings remains to be determined. Future work will focus whether other 
IL-1 family members, including IL-18 and IL-36 also contribute to bystander responses to 
L. pneumophila infection (Spörri et al., 2008; Towne et al., 2011; Vigne et al., 2011). 
Both IL-18 and IL-36 signal via MyD88 downstream of their receptors (Dinarello, 2013). 
It is of interest to determine whether these other MyD88-dependent signals contribute to 
the immune response against L. pneumophila infection as it is currently unclear which 
signal or signals contribute to the defect in MyD88-deficient mice. 
 
G. Bystander signaling occurs in other models of infection 
Other pathways to activate immune responses have been described for other 
pathogens. The proinflammatory form of cell death known as necroptosis may activate 
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immune responses to Y. pseudotuberculosis in vivo from uninfected bystander cells 
(Philip et al., 2014). Necroptosis has not been demonstrated during L. pneumophila 
infection as inhibiting pyroptosis prevents cell death (Casson et al., 2013). Inhibiting the 
production of reactive oxygen species (ROS) in intestinal epithelial cells infected with 
Listeria monocytogenes prevents CXCL2 production by neighboring uninfected cells 
(Dolowschiak et al., 2010). These data indicate that bystander epithelial cells are 
important for immune responses to L. monocytogenes and that ROS activates 
uninfected bystander cells. Similar experiments performed in macrophages infected with 
L. pneumophila, however, did not produce similar results (data not shown). These data 
suggest that ROS production does not play a role in bystander activation during L. 
pneumophila infection. Gap junction signaling is important for the propagation of 
bystander responses to S. flexneri and vaccinia virus infection in epithelial cells 
(Ablasser et al., 2013; Kasper et al., 2010). Inhibition of gap junction signaling during L. 
pneumophila infection in vitro, however, did not alter bystander cytokine production in 
macrophages (data not shown). Thus, a variety of signaling pathways initiated by 
infected cells are able to activate uninfected bystander cells to produce cytokines or 
chemokines important for controlling infection. These pathways are not important for all 
infections and others pathways may exist to induce bystander activation (Dolowschiak et 
al., 2010). 
 
In vitro, TNF and IL-6 are still produced by bystander bone marrow-derived 
macrophages in the absence of IL-1 signaling, indicating that other signals are released 
by injected cells to activate bystanders. Since injected cells, in spite of translational 
inhibition, synthesize IL-1α and IL-1β, other cytokines may be translated in injected cells. 
It remains to be seen whether IL-1α and IL-1β are the sole proteins produced robustly by 
injected cells. IL-18 is also released by the inflammasome, but the reagents for detecting 
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IL-18 are poor and often do not recognize all forms of IL-18 released from cells (Shida et 
al., 2001). Importantly, many inflammasome components are poorly expressed in resting 
cells and require NF-κB signaling for their expression (Lamkanfi and Dixit, 2009). As IL-
1α and IL-1β require the inflammasome for their release, these inflammasome 
components must be present in injected cells, indicating that these proteins may be 
translated in injected cells. Experiments to determine which proteins injected cells 
translate will be performed, including experiments to isolate polysomes to sequence 
which transcripts are associated with active ribosomes for translation. 
 
H. Final Conclusions 
I have identified a system used by the innate immune system to ensure the generation of 
proinflammatory cytokines during infection with an intracellular bacterial pathogen. My 
findings demonstrate the existence of heterogeneity in the production of critical 
protective cytokines by innate immune cells during the early response to bacterial 
infection and define a collaboration between infected and uninfected cells that enables 
the immune system to bypass protein synthesis inhibition and generate a robust immune 
response against L. pneumophila. As a variety of pathogens, including Yersinia spp., V. 
parahaemolyticus, S. flexneri, and others limit immune responses by inhibiting host cells 
signaling or protein translation, uninfected bystander cells may be required to carry out 
and amplify the early innate signals that eventually confer protective immunity (Fontana 
and Vance, 2011; Krachler et al., 2011). These bystander responses can be mediated 
by a number of pathways, including gap junctions, ROS production, cell death, and IL-1 
(Dolowschiak et al., 2010; Kasper et al., 2010; Philip et al., 2014). IL-1 is produced in 
response to a variety of infectious pathogens, and beyond its known role in recruiting 
inflammatory cells to sites of infection, may orchestrate the production of bystander 
cytokines in response to these pathogens (Dinarello, 1996). Therefore, the ability of IL-1 
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to induce bystander cytokine production and cell activation may be a key pathway to 
bypass pathogen-induced manipulation of host cell processes during immune 
responses, ensuring the production of a successful immune response and eventual 
control of infection. 
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Figure 5-1. Alveolar macrophages and neutrophils are targeted by the T4SS of L. 
pneumophila and contain viable bacteria during pulmonary infection. A variety of cells 
types exist within the mammalian lung including alveolar macrophages (AMΦ), dendritic 
cells (DC), natural killer (NK) cells, B cells, T cells, eosinophils (EΦ), and inflammatory 
monocytes (iMC) and neutrophils (NΦ). At 4 hours PI, alveolar macrophages in the 
airway space contain viable L. pneumophila and are targeted by the T4SS for injection. 
Activation of the immune response to virulent infection recruits inflammatory monocytes 
to the lung tissue and neutrophils to the tissue and airway space. Neutrophils, like 
alveolar macrophages, also contain vialbe bacteria at later times PI and are injected by 
the T4SS; whereas, inflammatory monocytes and DCs are not. 
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Figure 5-2. T4SS effectors block the production of cytokines in infected cells, yet IL-1α 
and IL-1β are still translated during infection. Cells infected with L. pneumophila activate 
several signaling pathways that induce the activation of NF-κB and MAPK. These 
pathways lead to the transcription of proinflammatory genes such as Il6, Tnf, Il1a, and 
Il1b. The T4SS effectors Lgt1, Lgt2, Lgt3, SidI, SidL, Pkn5, and Lpg1489 block early 
translation of TNF, but do not inhibit synthesis of TNF and IL-6 later post infection. 
Instead, TNF and IL-6 are inhibited by an unknown mechanism, either another bacterial 
effector or a host-driven response. IL-1α and IL-1β, however, are translated and 
activation of caspase-1 as well as capase-11 leads to the release of active IL-1 from 
infected cells. Whether infected cells release other inflammatory cues is unknown. 
 
  
Infected alveolar macrophage or neutrophil!
Lgt 1/2/3!
SidI/L, Pkn5!
Lpg1489!
!
Ribosome!
PR
R
 !
A
da
pt
or
!
NF-κB!
MAPK!
Il6, Tnf, 
Il1a, Il1b!
!
IL-1α!
IL-1β!
 !Caspase 1/11!
IL-1α!
IL-1β!
And ?!
115	  
 
Figure 5-3. Direct and indirect IL-1 signaling induces bystander cytokine production 
during L. pneumophila infection from uninfected innate host cells. Alveolar macrophages 
(AMΦ) and neutrophils (NΦ) infected with virulent L. pneumophila produce IL-1α and IL-
1β, but do not produce TNF, IL-6, IL-12, or express CD86. Certain bystander cell types, 
such as uninfected alveolar macrophages and dendritic cells, can directly respond to IL-
1 signaling in a cell intrinsic manner and produce TNF and potentially IL-12 as well as 
express CD86. Other cell types, such as uninfected neutrophils and inflammatory 
monocytes (iMC), do not demonstrably respond directly to IL-1, yet the absence of IL-1R 
signaling during infection impairs their ability to produce cytokines. Other cells, such as 
airway epithelia cells (AEC) produce chemokines like KC in response to IL-1 signaling 
and may produce other signals that act to stimulate cytokine production from 
inflammatory monocytes and neutrophils. This indirect response to IL-1 may explain the 
requirement for IL-1R signaling from these cell types. Whether other signals are involved 
in the activation of bystander cells during L. pneumophila infection has not been 
determined. 
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